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According to Gardner (67), Secretary of HEW:
No other national health problem has been so seriously neglected 
as alcoholism. The atmosphere of moral disapproval surrounding 
the entire subject, and the deplorable custom of treating alco­
holics as sinners or criminals have obscured the nature of the 
problem. But now we recognize that alcoholism is an illness - 
no more moral or immoral than tuberculosis or pneumonia or 
schizophrenia and that our ways of dealing with that illness 
have been shockingly inadequate.
There is a wealth of literature and voluminous books that abounds 
with the study of alcoholism. Many research efforts are being directed 
from many disciplines of science such as biochemistry, physiology, psy­
chiatry and pharmacology hoping that some rational approach to the pro­
phylaxis and treatment of alcoholism can be found. In spite of the mass 
of knowledge that have accumulated in recent years, there still exists a 
great deal of contradictions and inconsistencies in the understanding of 
the organic manifestations of the disease. Tremendous gaps are wide­
spread regarding the metabolic pathways of ethanol in man. Speculations 
have ranged from inborn metabolic errors to disturbances in the metabolism 
of nutrients and minerals to a deficiency in a series of enzymatic re­
actions to a score of other postulates attempting to provide a better
1
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understanding of the biochemical aspects of alcoholism.
Alcohol dependence is compulsive in nature and it has reached 
such a devastating magnitude of great complexity and scope that it has 
become one of the great public health problems of the world. In the 
United States, it ranks among the four major killers and is exceeded 
only by the cardiovascular and mental illness diseases (1). According 
to Block (11), five million people suffer from alcoholism. This means 
that about 6 per cent of our adult population or one out of every fifteen 




Drinking alcoholic beverages has been since time immemorial a 
part of the ritualistic ceremonies of most civilized people. The record 
of mankind from one era to the next unfailingly reflects the widespread 
use of alcohol as a source of social gaiety, sometimes with overindul­
gence and the tragic consequences. It is well known that the similarity 
in color of wine to blood had led some people to attach symbolic value to 
wine and hence the pledge of loyalty and friendship was extended to in­
clude betrothals, social gatherings and baptism.
The word "alcohol" is derived from the Arabic "Al-Kouhool" which 
refers to a fine powder of antimony used for staining the eye lashes. 
According to Poznanski (147), the discovery of late Stone Age beer jugs 
has established the fact that some use of fermented beverages existed in 
the neolithic period. The Egyptians attributing the cultivation of wine 
to Osiris, the Greeks and the bénéficient acts of Bacchus and the Hebrew 
tradition ascribing to Noah the art of wine manufacturing all point to 
the social role that alcoholic beverages played in early history. 
Hippocrates is said to have included wine in a list of therapeutics and 
used it as a wet dressing for ulcers.
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According to Block (12), alcohol as a medicine was first de­
scribed by Arnold of Villanova as a general panacea. He claimed that it 
was good for the old and for the young at every time and in every place. 
The Arab ian physician Rhazes is credited with the discovery of distilla­
tion in the 10^^ century. The European alchemists believed that alcohol 
was an antidote to senility and hence called it the water of life.
According to Jellinek (90), the clinical manifestations resemb­
ling the condition which is generally designated today as cirrhosis have 
been described in the early second century before Christ. In the Greek 
literature there are certain indications that damage to the liver by al­
cohol was alluded to by the medical writings of that era. The first sig­
nificant description of this condition was made by Mathew Baulie in the 
18*"̂  century although it did not exclude other etiological factors than 
alcohol in producing the disease.
In 1826, Laennec (after whom the syndrome was named) described 
the nodular characteristics of the atrophic liver which he specifically 
identified as the alcoholic form of cirrhosis, although this condition 
was later produced by agents other than alcohol. The term is still used 
today whether the condition is alcoholic or non-alcoholic in its origin.
Although alcohol has been used by man for many centuries, the 
development of scientific methods for determining the action of alcohol 
in the body is of comparatively recent undertaking. Prior to 1860, phys­
iologists believed that alcohol was completely oxidized in the body. 
Following this period, experimental research has shown that alcohol 
could be recovered in urine as well as expired air (69).
Modern study of alcohol metabolism did not start, however, until
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1870 when a group of investigators came to the conclusion that the body 
can utilize alcohol as a foodstuff. Widmark's micromethod for alcohol 
determination in 1922 was an important step toward the study of alcohol 
(12). In the following twenty years, the general facts about alcohol 
absorption, distribution and elimination in the animal and the human 
body were well established (89).
Definition of Terms
There are many definitions for alcoholism in the literature. 
Every individual seems to have his own idea of what constitutes.this 
illness. However, whether it is the casual observation of the layman or 
the rejected deliberation of the scientist, one thing is agreed upon and, 
that is, that alcoholism is manifested by extreme ingestion of alcoholic 
beverages. Few definitions by highly authoritative workers in their 
field seems to be necessary at the outset in order to distinguish the 
true character of this disease from the misconception that is held by 
the general public.
Jellinek (90), a former consultant on alcoholism to the World 
Health Organization defines alcoholism as "a progressive disease char­
acterized by an uncontrollable drinking". "Progressive" and "uncontrol­
lable" seem to be the key words in the definition. Clinebell (33) de­
fines an alcoholic as "anyone whose drinking interferes frequently or 
continuously with any other important life adjustments or interpersonal 
relationships". While these definitions are true statements and portray 
excellent characterization of the disease, they are nevertheless descrip­
tive in nature of the manifestation of the illness and hence do not dis­
play the mechanism of the disease itself.
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The official definition of alcoholism as reported by the World
Health Organization's Expert Committee (214) is a technical one and is
as follows:
Any form of drinking which in its extent goes beyond the tradi­
tional and customary "dietary" use of the ordinary compliance 
with the social drinking customs of the whole community concerned, 
irrespective of the etiological factors leading to such behavior, 
and irrespective also of the extent to which such etiological 
factors are dependent upon heredity, constitution, or acquired 
physiopathological and metabolic influences.
This definition is quite broad in its aspect of the disease without re­
gard for the various etiological factors that might be involved.
The American Medical Association (1) defines an alcoholic as 
"Those excessive drinkers whose dependence on alcohol has attained such 
a degree that it shows a noticeable disturbance or interference with 
their bodily or mental health, their interpersonal relations and their 
satisfactory social and economic functioning".
The definition proposed by Cain (26) for the term alcoholic is
"a person whose uncontrolled drinking is causing a continuing problem" 
and the term alcoholism, according to him, refers to "the collective be­
havior of a number of such persons". The concept of "alcoholism is a 
disease" has been debated repeatedly although the National Council on 
Alcoholism as well as the American Medical Association would like to 
think of alcoholism as a disease. Cain (26), however, argues that al­
coholism is "a disease of society", but not a physical disease caused 
by society.
According to Block (11), the ex-chairman of the AMA Committee 
on alcoholism, the term "alcoholism" is a general one describing "several 
species of social behavior and conduct associated with the excessive
7
ingestion of alcohol". He defines the term as "the use of alcohol or 
alcoholic beverages to the extent of causing any continuing adverse 
effect upon the individual or his family or community". Another term 
that has been adopted recently for alcoholism is problem drinking which, 
to some individuals, is more acceptable than the rather degrading term 
of "alcoholic" (26).
Jellinek (90), divides alcoholism into five different classes.
The first class he calls Alpha which is typified by a psychological de­
pendence with no apparent withdrawal symptoms or signs of progression.
This type may or may not progress further into other more dangerous types. 
The second class is termed Beta and is characterized by polyneuropathy, 
gastritis and cirrhosis, which for the most part is caused by nutritional 
deficiency and like Alpha type it does not display any withdrawal symp­
toms. The third class is the Gamma type, the most prevalent in our 
society. This type is characterized by increased tissue tolerance, adap­
tive cell metabolism, physical dependence and is usually accompanied by 
withdrawal symptoms or craving. The fourth class is the Delta type which 
shares the characteristic of the Gamma type, but differs from it in the 
inability to abstain. It is most prevalent in the wine-drinking countries 
and is often unrecognized unless withdrawal symptoms ensues. The fifth 
class is the Epsilon type which is also called periodic alcoholism or 
"occasional binge" drinking.
Other classifications have also been described, but these are 
sociopsychological rather than biophysiological.
The term "cirrhosis" is, according to Moon (129), synonymous 
with "chronic diffuse hepatitis". Any agent or combination of agents
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which produces chronic diffuse hepatic inflammation will result in some 
degree of cirrhosis. He suggests three essential features of the cirrho­
tic process:
(1) Degeneration and destruction of liver cells.
(2) Regeneration of liver cells from those which escaped destruction.
(3) Proliferation of connective tissue.
Probably the most concise and accurate classification of the 
cirrhotic process was given by Boyd (16). He states that after the orig­
inal use of the term by Laennec who employed the Greek word Kirros (towny) 
to describe the yellowish nodules on the surface of the liver, it was re­
alized that fibrosis was a striking feature of the lesions and hence 
cirrhosis came to be synonymous with fibrosis. The unfortunate thing, 
he indicates, is that the name suggests a disease entity, but according 
to him, the essence of cirrhosis is not fibrosis or scarring but destruc­
tion of liver parenchyma, followed by reconstruction of a new lobular 
pattern with the formation of regenerative nodules.
He contends that cirrhosis may be regarded as a chronic hepati­
tis with changes involving both the parenchyma and mesenchyma and hence 
fibrosis is secondary in nature rather than primary. He classifies 
cirrhosis into biliary which can be either intrahepatic or extrahepatic 
and portal or Laennec which can be either nutritional such as in alco­
holism, post-hepatic or post-necrotic in character. Furthermore, a mis­
cellaneous variety can include other descriptive terms such as pigmenta­
tion, cardiac, toxic and infectious.
Alcoholism as a Social and Public Health Problem
Although many people would like to blame alcoholic beverages in
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its various forms for the disease, the fact is that the individual who 
drinks to excess is the responsible one. As Cain (26) pointed out, it 
is just as illogical to blame gasoline for auto accidents as it is to 
blame alcohol for alcoholism. It cannot be assumed, for example, that 
communities with a higher level of per capita alcohol consumption than 
others have necessarily a higher case of alcoholics. By the same reason­
ing, a change in the level of consumption is not necessarily accompanied 
by a change in a similar direction in the incidence of alcoholism (188). 
Therefore, one must turn to the small percentage of every population who 
cannot safely drink alcohol because of some unique biochemical change 
that is either inborn in its nature or is developed after a long period 
of drinking.
A regular drinker is defined as one who drinks three times a 
week. Anything less than that is defined as occasional drinker. Seven­
teen per cent of the total drinking population in the United States are 
regular drinkers, 45 per cent are occasional drinkers and 38 per cent are 
abstainers (188).
Since alcohol can act as an anesthetic agent, it is conceivable 
that individuals who are faced with everyday problems wish to drink ex­
cessively in order to avoid facing facts of life, hence the inability of 
the individual to cope realistically with the problems of living and deal 
with them to the best of his ability is probably the major cause of al­
coholism. Block (12), refers to this state of behavior as "the prefer­
ence for escape into partial or total oblivion by means of an available 
drug which is the most common cause of alcoholism in our society".
The real causes of alcoholism, however, are still obscure. They
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have ranged from dietary deficiencies to personality traits to hormonal 
imbalance. Whatever the causes may be, establishing acceptable criteria 
is, undoubtedly, the first step to meet this illness as a public health 
problem. It is necessary to institute proper treatment so that the pro­
gression of the disease at the early signs can be effectively prevented. 
Understanding the physical and mental state of the individual may be im­
portant, but what is more important, however, are the mores and the social 
setting as well as the cultural and ethnic background which can give a 
better visibility for instituting a broad educational program. It can be 
hypothesized that effective measures of prevention must aim at changing 
philosophies and attitudes with realistic approach towards life that there 
are no problems without life and that there is no life without problems. 
This philosophy, I maintain, should be accepted particularly by young 
people as a part of normal life and any attempt for an escape by pallia­
tive intoxication into complete unreality must be considered an abnormal 
response. Many will agree that long range educational programs should 
be established by both private industry as well as governmental agencies 
to change people's attitude towards alcohol.
Within the perspective of public health many alcoholics may be 
regarded as "disease carriers" and their environment as "insanitary", 
hence the enormity and complexity of the problem. Combat team exploit­
ation is necessary whereby the physician working with the internal en­
vironment can cooperate with those working with the external environment - 
in public health education, social work and guidance (188).
As Cain (26) has suggested, a truly longitudinal study of indi­
vidual alcoholics should be done as opposed to statistical projects based
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on cross-sectional studies. This, he argues, would represent a research 
instrument for a true synthesis of the multidisciplined approach favored 
in today’s research circles. This would imply a truly long term study 
that embraces the function of the whole man in his total environment.
Physiological and Biochemical Changes in Alcoholism
Ethyl alcohol, the beverage kind, is only one of many alcohols. 
What distinguishes it from other alcohols which are non-potable is that 
the body oxidizes it rapidly, in contrast to methyl alcohol, (wood alco­
hol), for example, which would take a week for the body to destroy. Pure 
ethyl alcohol is a clear, colorless liquid with burning taste and little 
odor (69).
The distilled beverages usually have an alcohol content of 40 
to 50 per cent. The term "proof" as a measure of strength comes from 
early distillers, who tested alcohol by wetting gunpowder with it and 
when the distillate was at least 50 per cent alcohol, the powder would 
burn. Since combustibility of the gunpowder was 100 per cent of their 
alcohol content, 100 per cent proof came to mean 50 per cent alcohol (69).
Forty to fifty per cent alcohol is irritating to the lining 
tissues of the mouth, throat, esophagus and stomach. In moderate amounts 
it stimulates the gastric juice and promotes stomach motility, hence the 
sensation of hunger after alcoholic appetizers. A large intake of alco­
hol shifts water from the cell into interstitial fluid, hence the thirst 
that usually accompanies the hangover.
Alcohol is well absorbed into the blood without digestion. A 
small part is absorbed from the stomach, the rest passes into the small 
intestine and is absorbed from there very rapidly (188). Trace amounts
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of ethanol may also be synthesized endogenously (109, 134). The speed 
with wihich it reaches the brain depends to a great extent on the amount 
of the food in the stomach. Carbon dioxide in effervescent alcoholic 
liquors speeds up the passage of alcohol from the stomach and also mini­
mizes the irritation of the stomach.
In a 160-pound man, the alcohol in an ounce of whisky or a 
bottle of beer produces an alcohol blood concentration of about 0.02 per 
cent, and a half pint of whisky raises the concentration to 0.15 per cent 
which is the level at which most states (26) consider as permissible and 
not as drunken driving. Six states use 0.10 per cent, which is more re­
alistic. Only Utah uses 0.08 per cent. Many European countries use the 
uncompromising 0.08 cutoff point. Norway uses a stringent 0.05 per cent 
(7). According to Greenberg (69), intoxication is defined as "gross un­
mistakable disturbances of movement, coordination and intellect". A
blood concentration of 0.15 per cent is probably a realistic one, but
only if related to the signs and symptoms of intoxication, although with 
the present armamentarium of pharmaceuticals the so-called objective 
signs of intoxication are no longer valid and accordingly should be re­
evaluated due to the new advances in brain metabolism. In the words of 
Greenberg
The fact that drugs and black coffee appear to have a sobering 
effect does not mean that they hasten the disappearance of alco­
hol. These stimulants merely counteract some of the depressant 
action of alcohol on the brain and wake the person up. Awake 
or asleep the man is still drunk.
The first stage in the oxidation of alcohol is its conversion 
to acetaldehyde which occurs in the liver with the help of alcohol de­
hydrogenase (139, 197). Acetaldehyde is much more toxic if it accumulates
13
in the body (112, 192). Fortunately, it oxides rapidly into acetic acid 
which is broken down further into carbon dioxide and water. Antabuse, 
a drug used sometimes to control alcoholism is effective because it in­
hibits the oxidation of acetaldehyde (46). The drug has no apparent 
effect as long as the patient stays away from liquor, but if a small 
drink is taken, the acetaldehyde formed accumulates with severe and ex­
tremely unpleasant symptoms.
An ounce of whisky liberates 75 calories of energy, about as 
much as four and a half teaspoons of sugar. A drinker who consumes one 
pint of whisky a day gets 1200 calories of his daily energy requirement, 
but fails to get the minerals, proteins, and vitamins that the equivalent 
amount of food provides. Hence, excessive drinking often produces defi­
ciency diseases such as beriberi, pellagra and the degeneration of nerve 
fibers (69, 82).
The most pronounced physiological effect of alcohol is on the 
nervous system (1). A blood concentration of about 0.05 per cent of al­
cohol depresses the uppermost level of the brain, the center of inhibi­
tion, restraint and judgement. At a concentration of 0.10 per cent in 
the blood, from five to six ounces of whisky, alcohol depresses the lower 
motor area of the brain, hence depression of sensory and motor functions. 
A blood concentration of 0.2 per cent alcohol resulting from drinking 
10 ounces of whisky disturbs the mid-brain where emotional behavior is 
largely controlled. At 0.3 per cent from about a pint of whisky the 
drinker becomes stuporous. When the alcohol reaches the level of 0.4 or 
0.5 per cent, the whole perception area of the brain is suppressed and 
the drinker falls into a coma. However, different individuals and even
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the same individual at different times vary widely in their responses to 
a given amount of alcohol depending on the amount of food in the stomach 
and the kind of liquor drunk (1, 69, 82).
Other physiological effects that have been described are on the 
kidney through the pituitary gland where a reduction in its activity and 
hence, a reduction of the antidiuretic hormone which in turn produces 
copious urine (112). Other glands effected are the adrenals (165) which 
increase their secretion in the presence of large doses of alcohol, 
hence the disturbance of mineral metabolism in the body (6, 87, 94, 95, 
133).
The effect of alcohol on the heart and circulation has been sur­
rounded by many misconceptions. A drink of whisky makes the heart beat 
faster thus giving a sensation of warmth to the skin. This perhaps is 
due to a transient irritation of the nerve endings in the mouth and stom­
ach. This in turn increases blood flow, thus dilating the peripheral 
vessels, which in turn produces the feeling of warmth (69). Gillespie 
(67), on the other hand, concluded that the vasodilator effect of alco­
hol is not produced solely by peripheral sympathetic blockade or central 
inhibition, but rather as a vasodilator only when partly metabolized in 
the liver. Intra-arterially infused alcohol has a direct vasoconstrict- 
ing effect.
Eliaser and Giensircussa (48), however, believe that the thera­
peutic effects of alcohol in coronary artery disease are attributable to 
cerebral responses rather than demonstrable increase in coronary blood 
flow. There is no evidence that moderate amounts of alcohol cause heart 
disease, high blood pressure or atherosclerosis. Getting drunk, however.
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is believed to tax the heart and would be dangerous for a man with heart 
disease (48).
As for the effect of alcohol on longevity, it is agreed that 
heavy drinkers have a shorter life span than those who abstain or drink 
moderately. Nonetheless, there is no general agreement as to whether 
there is a difference between moderate drinkers and abstainers in lon­
gevity although insurance company records show no significant difference 
at all (1).
Alcohol as medicine has been used since time immemorial. Today 
rum is taken for a cold, although it does not cure a cold except for re­
lieving pain and discomfort. Whisky is given for snake bite, although 
it does not counteract the venom, but does relax the victim. Brandy is 
given to a person who faints although it has no direct effect on the 
fainting process except for reviving the patient by its irritation action. 
However, certain beneficial medical use of alcohol is still prescribed 
today. For example, a drink is prescribed for the elderly with arterio­
sclerosis due to the dilating effect of the alcohol on the blood vessels, 
relief from pain, and irritability and rousing their appetite. Also, it 
is used to provide caloric intake in the cases of patients who cannot 
be fed after an operation. As a source of food, however, the amount of 
alcohol that the body can burn is limited to about half an ounce per 
hour, hence a limited part of the energy needed can be supplied by alco­
hol. Furthermore, it must be realized that it does not provide certain 
essential micronutrients which come along with the ordinary food intake 
(82).
As for the psychological effect of alcohol it may be said that
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research is divided on this issue. Jellinek (91) summarizes the effect 
by saying that a small amount of alcohol increases skilled performance 
as the task becomes more complex. Thus small amounts which may produce 
relaxation usually interfere to some degree with efficiency, reduce 
verbal fluency and impair judgment and higher order of intellectual 
functioning. As for the emotional behavior, two ounces of wine hardly 
affected the emotional response to the sudden stress but 12 ounces di­
minished emotional responses very markedly (1).
It may be important to mention at this point one of the crucial 
differences between chronic alcohol intoxication and chronic opiate use. 
In opiate addiction, an individual functions well as long as he receives 
large enough quantities of the drug to stave off his abstinence syndrome. 
However, the chronically intoxicated alcoholic cannot function normally 
as long as he maintains an intoxicating intake of alcohol. Thus the 
chronic alcoholic suffers during intoxication while opiate addicts suffer 
primarily during abstinence. Evidences suggest, however, that withdrawal 
of alcohol from subjects protected from dehydration, avitaminosis and 
protein depletion can precipitate delirium tremens (85).
Rubin (159) presented evidence to explain the increased toler­
ance by alcoholics to drugs such as sedatives. He fed rats ethanol for 
two weeks along with diets either adequate or deficient in protein and 
choline. Hepatic lipids and the drug-metabolizing enzymes increased more 
in the deficient diet.
Ethanol and Muscular Myopathies 
Perkoff (143) described a clinical syndrome associated with bio­
chemical abnormalities in chronic alcoholism that resembles hereditary
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phosphorylase deficiency. The main features of this syndrome are muscle 
tenderness, increased serum creatine phosphokinase, poor lactic acid re­
sponse to ischemic exercise and a variable muscle phosphorylase activity. 
According to Wendt, £t al. (207), alcoholism and cardiovascular changes 
were recognized as early as 1873 by Walshe. Recently Eliaser and 
Giansircusa (48) identified three cardiovascular syndromes and designated 
them as alcoholic myocardosis, nutritional heart disease and beriberi 
heart disease. Evans (51) suggests an early diagnosis of alcoholic card­
iomyopathy with EKG which can manifest a depressed T wave, the presence 
of extrasystole, a bundle-branch blodk and a depression of S-T segment. 
Brigden (19) recognized several etiologic groups of cardiomyopathies 
among them is a condition he calls "alcoholic cardiomyopathies" which 
does not manifest itself with a development of beriberi. Gallop rhythm 
was common, and left ventricular failure was frequently encountered with 
progressively diminishing response to therapy including large doses of 
thiamine. Burch and Walsh (25) indicated that alcohol per se may have 
a direct toxic effect on the heart. They reviewed eight cases of alco­
holism in which they found a classical picture of beriberi heart disease 
as well as a typical non-specific heart failure. Wendt, et al̂. (207), 
tend to support the concept that chronic alcoholism results in altered 
myocardial metabolism even in those patients who do not display any clin­
ical evidence of heart or liver disease. This led them to classify 
chronic alcoholic patients into four groups on the basis of the hemo­
dynamic as well as the metabolic changes noted. Those with clinical 
evidence of heart or liver disease, those with alcoholic cardiomyopathy, 
those with Laennec's cirrhosis and those with both Laennec's cirrhosis
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and heart disease. They postulated, however, that with repeated bouts 
of alcoholism, the cellular and mitochondrial permeability as well as 
the metabolic pathways are altered. In support of this hypothesis, 
Ferrans and his co-workers (54) made a recent study of the cardiac muscle 
with alcoholic cardiomyopathy by electron microscopy and found the pre- 
scence of mitochondria swelling, a decrease in intramitochondrial enzymes 
and the deposition of liquid droplets in the myocardial cells.
Ethanol and the Pancreas
The so-called Zieve's syndrome has been described by Zieve (219) 
and subsequently by others (10, 18, 173). It is characterized by, hyper­
lipemia jaundice, fatty liver and hemolytic anemia. Sobel and Waye (173) 
found that incidence of pancreatic lesions was twice as high in patients 
with portal as contrasted to past necrotic cirrhosis. This suggested to 
them that pancreatic lesions are to be correlated with the alcoholism 
rather than with the liver disease.
Although the mechanism of hemolytic anemia is unknown, recent 
work by Beard and Knott (7) indicate that the chronic administration of 
ethanol resulted in the development of a normochromic normocytic anemia 
accompanied by a concomitant reticulocytopenia. There was also a gen­
eralized hypercellularity of the bone marrow with no change in the mye- 
loid/erythroid ratio. These findings led them to conclude that the path­
ophysiologic sequelae of chronic alcohol ingestion may result from a di­
rect depressive and toxic action of ethyl alcohol on the hematopoietic 
system.
Sullivan and Herbert (183) were able to correct this supression 
of the hematopoietic response with large doses of folic acid or by
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cessation of alcohol, hence the improvement seen in anemic alcoholics 
after hospitalization due to both ingestion of folate containing food 
and to cessation of alcohol ingestion. They speculated that the mechan­
ism involved here may be partly due to an effect on folate metabolism. 
However, Lindenbaum and Lieber (119) indicated that the dose related 
vacuole formation in RBC precursors due to alcohol could not be corrected 
with vitamin supplementation including large doses of folic acid.
Herbert, e^ (78), studied seventy patients with alcoholism 
and varying degrees of hepatic dysfunction. They found a significant 
correlation between serum folate deficiency and alcoholism, less signi­
ficance with either macrocytosis or anemia and borderline with cirrhosis 
and fatty hepatitis.
Psychopharmacology of Ethanol and Its Effect 
on the Nervous System
The physiological effect of alcohol on'the nervous system is 
probably the most pronounced effect to be described in detail by many 
workers in their field. Evidence is accumulating that alcohol or its 
metabolites produce at least some of its effects through the interaction 
of these various brain amines. Davis, e;t (40, 41), provide evidence 
supporting the fact that there is a "shift" in nor-epinephrine (NE) me­
tabolism from a normal oxidative route to a reductive pathway. The 
mechanism involved is the increased production of NADH resulting from 
ethanol oxidation hence a secondary "shift" in the metabolism of 3, 4 
dihydoxymandelic aldehyde and 3 methoxy-4-hydroxymandelic aldehyde to 
the corresponding glycols. Furthermore acetaldehyde form competes with 
the aromatic aldehyde for alcohol dehydrogenase; thus inhibiting their
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oxidation to the acids (41).
Duritz and Truitt (44) did not find any significant increases 
either in nor-epinephrine or in 5-hydroxytryptamine (5HT) after ethanol 
in rats. However, increased acetaldehyde blood levels produced by disul- 
firam pretreatment before the ethanol doses or by administration of ace­
taldehyde itself cause statistically significant decreases in brain nor­
epinephrine but no effect on 5HT.
It has been suggested (45) that the direct myocardial release 
of NE was due to acetaldehyde which has a stimulating action similar to 
that of tyramine. Towne (192) found amine levels of nerve cell-bodies in 
the catecholamine cell groups to be significantly affected by ethanol.
Thus the metabolism of acetaldehyde could contribute to a number of patho­
logic effects through the mechanism of NADH^ generation as well as 
through increased catecholamines release (112). Some ethanol effects on 
the nervous system has been attributed directly to the accumulation of 
acetaldehyde (44, 153, 192, 193).
Drugs are now available which in very small doses can have dra­
matic changes in behavioral pattern of the alcoholic. For example, chlor- 
promazine, a commonly used tranquilizer, delays the disappearance of al­
cohol from the blood in man (185). It also has the capacity to inhibit 
alcohol dehydrogenase although this has been challenged by Edwards and 
Price (46) who observed inhibition in vitro but not in vivo. Metroni­
dazole has also been reported to inhibit ADH activity and hence decreases 
alcohol consumption in man (46). The drug requirement for inhibitor is 
much higher in vitro than in vivo. Disulfiram (antabuse), as well as 
metronidazole, inhibit xanthine oxidase, a molybdenum activated enzyme,
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which is implicated in the metabolism of acetaldehyde.
Metabolism of Alcohol 
Perhaps there is no other drug whose metabolism has been studied 
so intensively as alcohol. Its value as a model for understanding the 
mechanism involved in other drugs has been exploited by many investiga­
tors (21, 159, 176). First, for better understanding of some metabolic 
processes of clinical relevance, second, as a means of modifying the 
action of other drugs in the liver and third as an agent that is capable 
of altering the structure of the liver cells.
Ethanol, when taken orally, is rapidly absorbed from the stom­
ach and the rest of the GI tract. About 2-10 per cent is eliminated via 
the kidney and the lungs and the rest reaches the liver via the portal 
vein. It is generally agreed that the site of ethanol oxidation is 
almost exclusively located in the liver (130, 166). Larson (106), how­
ever, found that when the concentration of ethanol in the blood reaching 
the liver is below 50-60 mg/1, the concentration in the liver vein, ob­
tained by catherization is zero.
The major metabolic pathways of ethanol are diagrammed in 
Figure 1 (77, 112, 138).
It is generally accepted by many workers in this field (39, 130, 
131, 136, 196) that the initial step in the disposal of ethanol is its 
catalysis by alcohol dehydrogenase, a zinc containing enzyme, which has 
been isolated in pure form from the soluble fraction of liver cells (136) 
with quantitative microtechnic. Morrison (130) found hepatic ADH to be 
3/5 more abundant in centrolobular areas of the liver than in peripheral 
areas in both man and rat, whereas Nyberg (136) obtained the reverse with
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Fig. 1— A general sketch of ethanol metabolism.
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histochemical procedures.
The end product of ethanol oxidation is acetate. This takes 
place in two steps:
Ethanol + NAD^ -> Acetaldehyde + NADH + H^
Acetaldehyde + NAD^ -> Acetate + NADH + h"̂ .
ADH catalyzes the first reaction and acetaldehyde dehydrogenase the se­
cond. The metabolism of acetate depends a great deal on its conversion 
to acetyl CoA via acetate thiokinase whose activity in the liver is very 
low. Hence most of the acetate formed is metabolized elsewhere in the 
body (77) where acetate thiokinase is relatively high. ADH, however, is 
mainly concentrated in the soluble fraction of the liver cell (192). 
Recently, however, Rubin (159) found that enzymes of the smooth endoplas­
mic reticulum are also capable of oxidizing alcohol to acetaldehyde, a 
system that requires NADPH and molecular oxygen.
Galambos, e^ (66) found an increase in glutamic pyruvic 
transaminase and lactic dehydrogenase in patients with liver disease 
given I.V. alcohol than in persons without liver injury. French (59) 
found a "shift" in succinic dehydrogenase histochemically localized to 
the centrolobular zone of rat livers fed ethanol. He suggested that this 
may be due to the ethanol-induced increase in permeability of the mito­
chondrial membrane. This led him to postulate that perhaps ethanol in­
gestion reduces some substances in the centrolobular zone that normally 
inhibits succinic dehydrogenase activity.
Mikata, at. (127), found a progressively impaired ethanol 
metabolism in cirrhotic rats as well as a decreased activity of hepatic 
alcohol dehydrogenase.
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Christophersen's (32) work on the liver mitrochondria suggests 
an increased stimulation of 0̂  uptake with 3-hydroxybutyrate as the sub­
strate whereas a decreased uptake with pyruvate, a-ketoglutarate and 
succinate as the substrate. He suggests, however, that ethanol increases 
the oxidation of the 6-hydroxybutyrate, by facilitating its transport 
into the mitochondria.
Kiessling and Tilander (100) studied the brain and liver content 
of thiamine diphosphate in rats given ethanol. This was moderately 
lowered in liver mitochondria and supernatant whereas its hydrolysis was 
partly increased in the supernatant.
Rubin and Lieber (157, 158) found mitochondrial alterations and 
focal cytoplasmic degradation within one day after giving ethanol in a 
concentration of 46 per cent of total caloric intake to humans. Fatty 
metamorphosis was noted within 3 to 10 days after the same dose and was 
associated with alterations of mitochondria and endoplasmic reticulum. 
This led them to conclude that alcohol exerts a direct toxic action on 
the liver. The same results were also obtained by other workers (64, 86, 
106, 160, 189).
Towne (192) did not find any alcohol dehydrogenase in brain 
homogenate, whereas its activity in the liver is easily detected. His 
results support the conclusion that acetaldehyde formed from ethanol oxi­
dation acts as non-specific inhibitor of liver monoamine oxidase.
According to Henley and Scholz (77), the metabolic fate of etha­
nol becomes of great concern as two molecules of NADH are formed from 
each molecule of ethanol. He suggests three possibilities which could 
be operative in taking care of the NADH.
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1. Synthesis of triglycerides and glucose.
2. Conversion to a metabolite such as lactate.
3. NADH transport into mitochondria to provide energy by oxidative 
phosphorylation.
Since there are other NAD dependent reactions located in the 
soluble fraction of the liver cells, they will be altered by competing 
with ethanol for NAD. These types of reactions that need NAD are lactic 
dehydrogenase, glycerophosphate dehydrogenase and glyceraldehyde phos­
phate dehydrogenase. Reduced metabolites of these reactions (lactate, 
glycerphosphate and glyceraldehyde phosphate) will increase in the tis­
sues while the oxidized form (pyruvate, dihydroxyacetone phosphate and 
3-phosphoglycerate) of the metabolites will decrease.
As has been found by Salaspuro and Maenpaeae (161) and Sholz, 
e_t (167), the administration of ethanol increases the concentration 
of lactate in the blood both in vitro (167) as well as in vivo (114, 116). 
The increased lactate permits the release of reducing equivalents into 
the blood stream, while that of glycerophosphate provides the three car­
bon skeleton for the synthesis of triglycerides and the glyceraldehyde 
phosphate dehydrogenase shifts the equilibrium towards glyceraldehyde 
phosphate from the oxidation of glucose to gluconeogenesis.
Although this postulate seems quite plausible from the biochemi­
cal point of view it does not fit in with the clinical side of the story. 
Brown and Harvey (22) found a clinical picture of hypoglycemia associated 
with alcoholic intoxication due to some form of denatured alcohol.
Cummins (38) reported two cases of hypoglycemia in children following 
ingestion of alcohol. He suggests that alcohol utilizes glucose as a
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metabolic poison and thus interferes with gluconeogenesis or may inhibit 
glycogenolysis. Hypoglycemia is more pronounced when the liver is de­
pleted of glycogen. Field, et ad. (55) consistently produced hypogly­
cemia in humans by the ingestion of 35-50 ml of ethanol after a two day 
fast. Besides inhibiting glycogen synthesis, he also found that ethanol 
interfered with urea formation in the isolated, perfused rat liver, but 
not with amino acid mobilization. Freinkel, et al. (58), drew the same 
conclusion after an overnight fast.
Henley (77) suggests, however, that in well-fed man or animal, 
the blood sugar may rise due to the action of catecholamines, which will 
promote the formation of glucose from glycogen stores.
Madison (124) postulated as diagrammed in Figure 2 that ethanol 
inhibits gluconeogenesis because of the marked increase in the ratio of 
NADH^/NAD. This, he suggests, permits a unitary explanation for several 
puzzling phenomenon. First, it will allow for the increased fatty acid 
synthesis. Second, it explains the decrease in hepatic conversion of 
galactose to glucose. Third, it justifies the decreased transformation 
of serotonin to 5-hydroxyindolacetic Acid (5 HIAC). Fourth, it gives a 
logical rationale for the decreased glycerol metabolism, the depression 
of the Krebs cycle and the decreased conversion of amino acids to glucose.
An additional factor that should be considered in the metabolism 
of ethanol is the fatty acids which are increased in starvation due to 
their increased production of acetyl CoA and possibly by inhibition of 
glycolysis by citrate. It is not known, however, whether fatty acids 
are produced de novo or are mobilized from adipose tissue into the liver.
Bouchier and Dawson (15) infused 1.0 g ethanol/kg body weight
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Fig. 2— Reduction of NAD to NADH2 during ethanol oxidation and the pathways for disposition 
of the ethanol-generated reducing equivalents.
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over 30 minutes and noted a decrease of free fatty acids (FFA) during 
infusion and an increase after the infusion had been stopped. He con­
cluded that FFA is mobilized from adipose tissue via adrenaline. Brown 
(21) administered ethanol to rats orally and found a lower serum FFA and 
lower liver triglyceride. DiLuzio and Poggi (42) provided further sup­
port to the concept that depressed intrahepatic triglyceride is a factor 
in the development of steatosis following acute ethanol intoxication. 
Contrary to that, Elko, £t a]̂. (49) presented data indicating a signifi­
cant increase in hepatic triglycerides 4-16 hours after alcohol intuba­
tion into rats. He does not subscribe to the idea that ethanol intoxica­
tion enhances lipid mobilization. Lieber, e^ (116) observed a fall 
in FFA levels during ethanol administration, but were unable to find any 
evidence that ethanol induces mobilization of FFA from the extremities. 
Thorpe and Shorey (189) found decreased serum FFA after 4 months of alco­
hol administration but no change in serum triglyceride and albumin levels.
To assess peripheral lipid mobilization, Feinman and Lieber (53) 
investigated the effect of ethanol on plasma glycerol and FFA in alco­
holic volunteers. They found a drop in plasma FFA and glycerol 46 per 
cent and 36 per cent respectively from baseline values. They did not 
detect any change in glucose levels. Hence their data support the find­
ings of a reduction in peripheral lipid mobilization after ethanol.
French (62) found an increased phospholipid in livers of both male and 
female rats fed ethanol. It would seem, therefore, that the lipid that 
accumulates in liver has three obvious sources: dietary, whose magnitude 
depends on the amount of fat taken in, endogenous synthesis, and mobili­
zation of peripheral fat depots which may be important only when large
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quantities of alcohol are consumed.
As to the mechanism and cause of fatty liver development in the 
alcoholic, Salaspuro and Maenpaeae (161) and also Lieber and DeCarli (113) 
presented data to indicate that the oxidation of fatty acids and the 
citrate cycle are strongly inhibited during ethanol oxidation as demon­
strated by lowered carbon dioxide production. Hence the "shift" toward 
fatty acid synthesis due to its replacement by ethanol in the energy- 
yielding process and the similarity of the NADH generated from the oxi­
dation of ethanol to that generated from the oxidation of fatty acids is 
the main cause for the development of a fatty liver in the alcoholic (5, 
37, 111).
It would seem, therefore, from the foregoing evidence that 
ethanol interacts with NAD which causes a fall of the NAD/NADH^ ratio in 
the liver. Consequently a rise of lactate/pyruvate ratio follows. The 
decrease in the pyruvate causes an inhibition of gluconeogenesis accom­
panied by a rise in a-glycerophosphate concentration in the liver. All 
of these changes lead to the accumulation of fat in the liver, hypogly­
cemia, hyperlactemia and hyperuricemia (Figure 2). Krebs (105) contends 
that the NAD/NADH^ ratio of the cytoplasm and mitochondria are maintained 
and regulated within relatively narrow limits and any condition that up­
sets their ratio leads to pathogenesis of the liver. In support to this 
contention, Dajani and Kouyoumjian (39) conducted in vitro studies and 
were able to find a correlation between the concentrations of hepatic FFA 
as well as triglyceride with the levels of liver ADH and NADH^.
As to the effect of ethanol on ATP, French (60) presented evi­
dence indicating an increase in acute treatment with ethanol and a
30
decrease after chronic ingestion. This was attributed to degenerative 
changes in liver mitochondria as reported by Kiessling and Tilander (100) 
and Kiessling and Pilstrom (101, 102).
Experimental Liver Cirrhosis and Ethanol
Alcoholic liver cirrhosis has never been reproduced in experi­
mental animals, although fatty liver has been produced by many investi­
gators (23, 24, 105, 146). It is well established that fatty liver may 
precede the development of cirrhosis, but it is not clear whether there 
is cause and effect relationship. Recently, however. Porta, £t (146) 
described a procedure of producing fatty livers, hepatofibrosis, cirrhosis 
and Mallory bodies in rats that have been put on diet deficient in lipo- 
tropes (146).
Many agents have been described in the literature to produce 
cirrhosis. In reviewing these agents Moon (129) included various agents 
both inorganic elements such as phosphorus, arsenic, lead, manganese, 
copper and organic substances such as alcohol, chloroform, tar, carbon 
tetrachloride and related substances, infectious and bacterial products 
of protein decomposition and immune serum. He suggests that alcohol may 
accentuate the injurious effects of these agents. White, et a]̂. (209) 
were able to produce cirrhosis in the rat by total body irradiation. 
Compos, ^  (27) conducted similar experiments except that the carbon
tetrachloride was given by inhalation daily for 7 weeks, in conjunction 
with 9.5 per cent ethanol in drinking water. They suggested that cir­
rhotic changes in the liver increase the fraction of ethanol lost by non- 
oxidative means. Bunyan, et al. (24) gave carbon tetrachloride orally 
2.0 ml/kg to study the ATP level in the liver. There was a slight
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decline which could not be prevented by vitamin E. This suggested to 
him that carbon tetrachloride does not increase lipid peroxidation in 
vivo. Fischer (56) produced acute carbon tetrachloride poisoning by 
giving rabbits 2.5 ml/kg I.V. in which alcohol elimination was increased. 
This, he contends, supports the hypothesis that the liver NAD/NADH ratio 
effected alcohol elimination.
Solodkowska, ^  (174) used carbon tetrachloride induced
cirrhosis to study the incorporation of carbon-1 of ethanol into lipids 
in both "drinker" and "non-drinker" strains. The rate of combustion of 
C-1 ethanol to CO^ was significantly higher in carbon tetrachloride 
treated rats than untreated.
Paradoxically, Loyke (121) treated experimental hypertension in 
rats with carbon tetrachloride. This suggested to him that liver injury 
caused by carbon tetrachloride is associated with formation of a substance 
that inhibits circulating converting enzymes.
Cornish, £t (34) studied serum enzyme response in rats after 
they were given a variety of alcohols 18 hours prior to carbon tetra­
chloride exposure. They found a highly significant potentiation of the 
enzyme. Cartier and Leroux (29) studied carbon tetrachloride poisoning 
in rats to determine its effect on the acid soluble free nucleotides of 
the liver. They found a 30 per cent decrease in pyridines, purines and 
ATP. These effects, he suggests, appear to be due to an alteration of 
the respiratory functions of liver mitochondria through alterations of 
oxidative phosphorylation. Lawrence and Sanat (107) used carbon tetra­
chloride poisoning to study the portal and hepatic beds. Shunt develop­
ment correlated well with the general deterioration of liver function.
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Reichard (152) investigated alterations in ornithine carbamyl transferase 
during severe carbon tetrachloride poisoning. Edwards and Dalton (47) 
gave carbon tetrachloride in olive oil in doses of 0.04cc to mice and 
were able to produce cirrhosis within a period of six weeks. When the 
compound was removed, conditions were restored to normal within one month.
Rubin, e^ (156) studied the mechanism of carbon tetrachloride 
induced cirrhosis in rats. They found striking proliferation of mesen-
3chymal cells. They also noted a diminished uptake of thymidine-H by 
hepatocytes and a progressive rise in DNA content. During non-septal 
fibrogenesis, collagen measured as hydroxyproline increased in like 
manner. During septal fibrogenesis, however, collagen increased out of 
proportion and the hydroxyproline/DNA ratio doubled, a fact, which they 
suggest might reflect irreversibility of cirrhosis.
Some workers, however, contend that there are differences in 
strain susceptibility to induction to cirrhosis in experimental animals. 
Patek, et â . (142) found this susceptibility to be greater in the Wistar, 
less in the Sherman and considerably less in the Long-Evans. They sug­
gested that conditions other than food intake such as constitutionality 
might be responsible for the difference.
Gillespie and Lucas (68) provided further evidence that the 
source of supply as well as the type of strain used may be an important 
variable. Arvola and Forsander (2) found similar variation and inter­
individual fluctuation of the voluntary intake of alcohol by laboratory 
rats and mice, but the average alcohol consumption within a species of 
animal was constant.
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The Etiology of Alcoholism: Heredity vs Environmental
and Nutritional Factors
There is a wide variability among individuals in the amount of 
alcohol required to bring about signs of intoxication or impairment of 
function. This fact led Williams (211) to postulate that environmental 
factors do not bring about alcoholism unless the individual involved 
possesses the type of "metabolic individuality" which predisposes toward 
addiction such as the pathological intoxication or drug idiosyncrasy. 
Hence, psychological stresses do not make a person an alcoholic unless 
he has inherited a metabolic pattern. Williams, et̂  al.- (212) presented 
evidence to show that alcoholism is a genetotropic disease which is de­
fined by him as a disease in which genetic factors and nutritional defi­
ciencies together are the etiological agents. The experimental work they 
did on rats (213) demonstrated that sugar consumption, as well as alco­
hol consumption are increased by deficient diets. Mardones (125) pre­
sented data to the effect that there is a genetic factor in alcohol pre­
ference in rats. Animal experiments, however, particularly those of 
Best (9) have established beyond any doubt the importance of dietary 
supplements, particularly lipotropic factors, in the prevention of nutri­
tional liver damage. His conclusion suggests that an imbalance between 
caloric intake and supply of accessory food factors is the cause of liver 
disease. Lester, et al. (109) do not support this same view.
Although many workers in this field (13, 23, 24, 63, 108, 141, 
206, 213) provided evidence along the same line as that of Best, namely, 
that low protein diet (6%-30% casein) developed cirrhosis in rats these 
conditions often aggravated but did not cause the liver damage. Experi­
mental evidence as to whether ethanol in the presence of a normal diet
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can bring about an increased triglyceride formation in the liver was 
provided by Lieber and DeCarli (113) and Lieber and Spritz (115) who 
demonstrated that partial protection from alcoholic fatty liver can be 
achieved with large amounts of DL-methionine or choline with an average 
reduction of 80 per cent of triglyceride accumulation in the liver.
Takada, £t al. (186) confirmed these results by providing further 
proof against the hypothesis that alcohol is cirrhogenic in humans by 
direct hepatotoxic action. They contended that this can afford hope for 
achieving some recovery of liver function if high protein diet is con­
sumed containing abundant vitamins and essential food factors simultan­
eously with alcohol. Porta, e^ (145) presented data to indicate that 
when alcohol provides less than 30 per cent of the total caloric intake 
of rats, harmful dietary imbalances do not result as long as the basal 
food mixture is reasonably adequate. However, Rubin and Lieber (157) do 
not agree completely with this concept. Their data do not exclude the 
possibility that chronic malnutrition may exacerbate alcohol-induced 
liver injury, but also demonstrate that alcohol itself is toxic to the 
liver, independent of nutritional factors. In a paired feeding experi­
ment, Lowry, jê  (120) supported this view that alcohol increases the 
severity of the liver cirrhosis when rats are put on deficient diets. 
Furthermore, Kasliwal, et al. (96) presented data to support the same 
view and concluded that undernutrition may hasten cirrhogenesis by rend­
ering the liver more vulnerable to the ill effects of hepatotoxic factors.
If alcohol is isocalorically replaced by sucrose, however, su­
crose-fed animals show significantly more hepatic lipid than alcohol-fed 
rats (145). When sucrose-fed rats are put on a fortified diet, "Super
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Diet", animals again showed a higher concentration of hepatic lipid than 
controls (186). In the perfused liver, the rat, unlike man, can make a 
histologic recovery from cirrhosis provided it receives an adequate diet 
(186).
As for the effect of ethanol on vitamins such as riboflavin, 
pyridoxine, thiamine and such lipotropic factors as choline, French (61) 
measured the changes in rat liver dehydrogenase and concluded ethanol in­
gestion is more deleterious to pyridoxine-deficient rats than controls.
In a separate experiment (62), he showed that chronic ethanol feeding 
produced fatty changes in the liver and focal fibrosis, but not cirrhosis, 
particularly in vitamin deficient rats. Suomaleinen (184) gave 10 
per cent ethanol to rats and found an immediate increase in the excretion 
of thiamine, pyridoxine and pantothenic acid. He observed no change in 
methionine, cobalamine and folic acid. Mardones (125) increased the al­
cohol intake of rats maintained on a diet deprived of thermolabile ele­
ments of the vitamin B complex, hence he advocated the use of geneto- 
trophic etiology as a working hypothesis in the study of human alcoholism.
Wilgram (210) produced the Laennec's type of cirrhosis in mon­
keys and was unable to reverse the histological picture when animals were 
put back on a fully nutritious regimen. Auto-immunization against liver 
cell protein was considered by him as a possible etiology.
Dimberg, £t al̂. (43) found increased serum enzyme values of 
glutamic-oxalacetic transaminase (GOT), glutamic-pyruvic transaminase 
(OPT) and creatine phosphokinase in patients given a diet poor in car­
bohydrate which suggests liver and muscle damage.
The question that is raised by many is what would the effect of
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the alcohol be on the liver that is already the site of cirrhosis. The 
answer was provided by Erenoglu, et. (50) who gave alcohol daily to 
cirrhotic patients. One group received a nutritious diet and the other 
was restricted in protein. The first group of patients made steady im­
provement while in the second group there was definite deterioration.
As indicated earlier, ethanol suppresses Krebs cycle activity in the 
liver. In man, unlike the rat, there is no way of reversing the lesions 
of cirrhosis once it sets in, although it has been shown that continued 
alcohol consumption with adequate diet such as in hospitalized patients 
is compatible with clinical improvement. According to Gyoergy and 
Goldblatt (72), tocopherol is an additional protective dietary factor 
which may compensate for the absence of sulfur-containing amino acids.
In a similar experiment Gyorgy and Goldblatt (73) were able to reduce 
liver injury by giving from 10 to 20 mg choline daily whereas addition 
of 50 mg cystine daily accentuated liver cirrhosis.
Trace Metal Metabolism and Its Relation 
to Human Diseases
The literature on trace elements and its relationship to health 
and disease is immensely widespread. Trace-metal deficiencies have been 
known from the earliest historic times such as treatment of iron defi­
ciency anemia with iron salts during the Roman times and the treatment 
of goiter with the ash of sponges which contain iodine by the Greeks. 
Hippocrates is known to have prescribed rusty water to restore vigor to 
pale persons. The physiological and biochemical role that they play in 
health and disease, however, is relatively of recent undertaking.
Although the term trace elements is used widely among various
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disciplines of science it does connote to some, however, the idea that 
these elements do not play an important role. The term has been defined 
by many workers in this field, but it is generally agreed that any ele­
ment that comprises less than 0.01 per cent of the organism is called a 
trace element (169). They are also known as micronutrients, oligonutri- 
ents or minor elements as opposed to macro or bulk elements. The desig­
nation "trace", however, often refers to the extent of our technical and 
analytical ability of detecting that particular element in biological 
material rather than its relative concentration. Hence, our concept of 
a "trace" keeps changing as we keep improving our method of detection.
For example, according to a comment made by Vallee (196), zinc has lost 
its standing as a "trace" element because of its broad base of biologi­
cal importance that has been recently discovered.
In the early twentieth century, the term "accessory food fac­
tors" was coined by Sir Frederick Gowland Hopkins. We recognize these 
factors today as vitamins. Although the metabolic importance of these 
compounds and their essentiality in the total economy of the organism 
at the cellular and enzymatic levels have been explored extensively, 
their counterpart, the trace metals, had to await the purified diet era 
in the early thirties in order to elucidate their role in the biological 
system. This was due to the fact that tools for their study were not 
available and even more important the advent of newer tools of biochem­
istry to isolate and characterize metalloenzymes were lacking. Today 
we recognize trace elements as an important part of the whole armamentar­
ium of the biochemical makeup of the organism. They are associated with 
co-factors and enzymes for growth, repair, regeneration, homeostasis and
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nutrition by acting on an electrochemical, catalytic or structural level 
of the cellular components.
In spite of much speculation as to how metals function in these 
enzymes, David Green's comment (70) that enzyme catalysis is the only 
rational explanation of how a trace substance can produce profound bio­
logic effect seems to be pertinent at this point. However, one popular 
concept is that metals act as a bridge between substrate and the protein 
which activates the metal by withdrawing electrons from it, hence becom­
ing positively charged and thus enabling it to withdraw electrons from 
substrate. A chemical change is precipitated and hence the free energy 
of activation is lowered by the electronic alteration mediated by the 
metal.
In other instances the metal plays an important role in the 
tertiary folding of the protein which may have to bring together two or 
three amino-acid residues that are located far apart on a polypeptide 
chain, but which may become active when brought into the proximity of 
each other. It is believed that metals are bound to proteins mainly by 
the histidine residues in the protein.
There are over 2000 enzymes that regulate a vast number of chemi­
cal reactions within the cell. Trace elements supply what Kench (99) 
calls the "Cationic Climate" and how a preferential absorption of certain 
trace elements can either block or promote enzyme activity and hence 
alter the entire biochemistry of the cell. To quote Kench (99) connection 
seems appropriate as to the important role of trace elements.
The wealth of living forms is reflected at the cellular and 
sub-cellular level by a vast number of possible molecular 
inter-relationships, among which the relatively indestructible 
metal ions appear to have been exploited fully in a directive
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capacity, accelerating or decelerating the rate of structural 
change of the more evanescent carbon compounds, helping to 
provide the metabolic bridges and feed-back.
Enzymes activated by trace elements are divided into two classes 
according to Parisi, e^ (140): (1) metalloenzymes, which have a fixed 
amount of specific metallic ions firmly bonded to enzymes and whose 
metal/enzyme ratio is constant, (2) metal-activated enzymes or metal pro­
tein complexes where the metal is reversibly bonded to enzyme with a 
variable metal/protein ratio. Metals may substitute for each other and 
may also be removed by dialysis in the latter type of binding.
There are over thirty-seven elements out of the 102 in the 
periodic table that have been found in the human body (80). Twenty-six 
of these are metals and are present in only trace amounts some of which 
are too little to be detected by our present technique. According to 
Schroeder (169), there are 9 inorganic essential micronutrients, 7 metals 
and 2 non-metal. Four cause deficiency disease and three cause disease 
of accumulation. Ten elements have the capacity to be essential, four 
alkali or alkali earth and thirteen heavy metals to which modern man is 
exposed.
Schroeder (169) lists three types of trace metal deficiencies. 
These include simple deficiency such as iron and copper in man and Mo 
and Co in other mammals, and malabsorption or decreases in carriers of 
the blood such as zinc in Laennec's cirrhosis of the liver. Although 
overt toxicities of trace elements have been well established experiment­
ally as well as clinically, small chronic exposure over long periods of 
time is not well defined. There are also excesses of trace elements, 
certain diseases such as Wilson disease and copper accumulation (8, 195),
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and Parkinsonism and high manganese concentrationism (35). Other types 
of excesses may be due to other large dietary intakes, increased absorp­
tion or decreased excretion resulting from other disorders such as in 
biliary obstruction or renal insufficiency (169).
In spite of much speculation regarding essentiality of trace 
metals, several workers in this field (36, 144, 168, 191, 194) agree on 
the criteria for essentiality. First, it is present in all healthy tis­
sues of all living things. Second, its concentration from one animal to 
the next is fairly constant if compared to non-essentials; even the vari­
ability of human organs as found by Perry, e^ (144) was more alike 
with respect to the absolute concentrations of essential than of non- 
essential metals. Third, its withdrawal from the body induces in a re­
producible fashion the same structural and physiological abnormalities 
regardless of the species studied. Fourth, its addition either prevents 
or reverses these abnormalities. Fifth, the abnormalities manifested 
by the deficiency state are always accompanied by pertinent, specific 
biochemical changes. Sixth, these biochemical changes can be cured or 
prevented when the deficiency is corrected. Hence, by these criteria 
a beneficial effect on growth or reproduction does not qualify an ele­
ment as essential.
Schroeder (169), however, has formulated a criteria of essenti­
ality quite different. He contends that any element concentrated by the 
plant is essential. Such a rule is not always true, for example, lithium 
and rubidium are widely distributed in plants and yet they are not proven 
to be essential for man yet. Although elements may be present at a very 
low concentration it is conceivable that all of them may be present in
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biological material even though we may not be able to detect them. Fur­
thermore, lack of awareness of the importance of trace metals, in the 
biological system, has hampered their study. Recently, however, new 
tools have appeared on the horizon which have enabled us to determine 
qualitatively and for some elements quantitatively, concentration at the 
cellular level such as in various parts of the nephron (217) or the gut 
wall (154) by the use of such sophisticated tools as the laser and elec­
tron microprobes.
Various other analytical techniques such as emmission spectro­
scopy, atomic absorption, and neutron activation as well as mass spectro­
scopy have contributed a great deal to our understanding of trace metal 
distribution in the organism and particularly in man.
In spite of our great strides in trace metal biology we still 
lack a unified biological standard as a frame of reference and hence in 
reporting the amounts of trace metals in biological material, different 
observers used different frames of reference and different measures of 
central tendency. Thus, Nusbaum, e^ (135) reported values as con­
centrations in dry tissue. Koch, e^ al. (104) reported their results in 
modified dry ash. Thiers and Vallee (187) have used nitrogen content as 
the reference in calculating concentrations in cell fractions. Tipton 
and Cook (191) used micromoles of metal per gram tissue ash. We (215, 
218) have always reported on concentrations in dry ash but also have 
given the ratio of dry ash to wet weight in different organs, because 
different organs ash differently. It is obvious, then, that there is an 
urgent need of securing better standard materials and a more unified re­
porting system in order to make inter-laboratory comparison more
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meaningful.
Trace Metal Alterations and Their Relation 
to Health and Disease
Pathological alterations of trace metal metabolism is widespread 
in the literature (3, 71, 79, 92, 104, 110, 175, 190, 208). We (218) 
have reported trace metal alterations in autopsy material for four dis­
eases: diastolic-hypertension, bronchogenic carcinoma, hepatic cirrhosis 
and myocardial infarction. Preliminary data for 5 patients from each of 
the 5 groups (including control group) are tabulated in Appendix I. We 
also sought differences between normal and arteriosclerotic aorta for 
trace metal content (216). There was a significant decrease in copper 
and zinc (Appendix II).
Magnesium
It is well established now that shifts in body magnesium have 
deleterious effect and can produce significant clinical manifestations 
(204, 205). The entire body of an adult contains about 25 g. It is 
the fourth most abundant cation being exceeded only by calcium, sodium, 
and potassium. Hence, the term "trace element" similar to that of iron 
can hardly be applied in this situation. Like potassium, it is mainly 
intracellular with a concentration of 26 mEq/1 as compared to 151 mEq/1 
potassium and 15 mEq/1 sodium. Approximately half of the magnesium re­
sides in the skeleton and exchanges very slowly with the extracellular 
ions. The highest concentrations of magnesium are in the liver and 
muscle followed by the brain, kidney and red blood cells (203).
About one-third of the serum magnesium is bound to albumin and 
globulin and the remainder is in ionic form (203).
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Magnesium is known to perform a large variety of functions. It 
activates a wide variety of enzymatic systems and frequently it acts as 
a necessary co-factor for enzymes concerned with hydrolysis and the trans­
fer of large groups such as the magnesium activated adenosine-triphospha- 
tase of mammalian muscle. It is also known to act as an irreplaceable 
link in keeping the ribosome components together as well as the bridging 
of the ribosome and m-RNA (205).
Magnesium is depressant to both the central nervous system and 
the peripheral nervous system and is known to maintain the normal excit­
ability of neuromuscular junction.
The average intake of magnesium for an adult is approximately 
300 mg although requirements may vary between infants and under certain 
conditions such as in pregnancy. Two-thirds of the magnesium intake is 
absorbed and that which appears in the kidneys causes diuresis, of this, 
normally 35 per cent is reabsorbed by the tubule (75). Diuretics which 
decrease the excretion of potassium increase the excretion of magnesium 
and vice versa. Aldosterone is known to increase the excretion of both 
(203). In renal failure, both magnesium and potassium are retained (205).
Diseases known to be caused by a shift in the metabolism of mag­
nesium are widespread. Miller (128) described a normocalcemic, hypomag­
nesemia tetany. Martin, et (7) reported a magnesium depletion in 
heart failure and chronic nephitis. Smith and Hammarsten (170, 171) de­
scribed low plasma magnesium in delirium tremens which was followed by 
improvement when magensium was administered.
Increased concentrations of plasma magnesium is associated with 
renal failure (170). This, however, is not always associated with renal
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failure. Hills, al̂. (81) described adrenal insufficiency in which 
there was high level of plasma serum. There are conflicting reports as 
to the levels of magnesium in portal cirrhosis and diabetes millitus (178).
Iron
Iron, like magnesium, can hardly be called a trace element since 
it is highly concentrated in the body. It is a vital constituent of the 
porphyrin enzymes such as the catalases, the peroxidases, and various 
members of the cytochrome system. The latter system is extremely import­
ant in the metabolism of all living cells. It is also an important con­
stituent of the oxygen-transfer substances such as hemoglobin and myo­
globin, transferrin which reduces the concentration of the ferrous ions 
in the blood and ferritin which transfers iron from the GI tract to other 
tissues. Among the non-porphyrin enzymes in which iron is an essential 
constituent are aconitase, aldolase and fumaric hydrogenase (194).
Concentrations of iron in the body varies with the species, age, 
species, nutrition, and state of health. Liver and spleen rank the high­
est in iron content, followed by kidney, heart, skeletal muscles, pancreas 
and brain (194).
Normally, the major part of iron is bound to a specific iron- 
binding protein, called transferrin. Other forms of iron have been de­
scribed, such as the acid soluble iron and the plasma hemoglobin iron.
Excesses and deficiencies of iron have been described in the 
literature. Increases in the iron content of liver have been reported 
in human malignancies and chronic infection (190). A peculiar abnormality 
in iron metabolism occurs in hemochromatosis in which up to 50 g of iron 
can accumulate in the body. Excess dietary iron in alcoholic liquors
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has led some investigators (31, 122, 123) to blame this source for a 
possible association between excessive consumption of alcohol and the 
development of iron overload. Deficiency states are well known in iron- 
deficiency anemia.
Zinc
Approximately 2.2 g of zinc are found in an average adult. The 
highest concentrations are found in the prostate and the retina: most 
other organs contain on the average 20-30 ug/g wet weight. Whole blood 
contains about 9.0 ppm (150).
One-third of the zinc is bound to globulin and the rest is 
loosely bound to albumin for transport purposes. Zinc forms an integral 
part of carbonic anhydrase and alcohol and lactic dehydrogenases (97, 
196).
The average daily intake of zinc is about 12-15 yg, 4 per cent 
of which is excreted in the urine and the remainder is excreted in the 
feces. Very little of the absorbed zinc is excreted in the bile (196).
Although zinc deficiency causes paraketosis in swine the occur­
rence of uncomplicated primary zinc deficiency is not well established 
in man except for the work reported by Prasad, e^ â . (148). Vallee,
^  sd. (199, 200) reported a marked decrease of zinc in the serum of pa­
tients with post-alcoholic cirrhosis as well as of patients with myo­
cardial infarction (172). Low values of zinc were also reported in ma­
lignant tumors, hepatogenic jaundice and chronic nephritis. Vikbladh 
(201) observed low levels of serum zinc in leukemic patients. Vallee 
and Gibson (198) noted 10 per cent less zinc in the white blood cells of 
patients with myelogenous and lymphatic leukemia. Herring, al. (79)
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reported low levels of plasma zinc from patients with untreated pernicious 
anemia. Zinc levels were back to normal after patients were treated with 
vitamin Statistical analysis by Herring, e^ (80) showed no
significant differences attributable to age or sex although mean plasma 
values for zinc were lower in the second and third decades than in the 
fourth decade.
Copper
It is estimated that the human body contains approximately 100- 
150 yg of copper, most of which is concentrated in the liver and the cen­
tral nervous system. Spleen and bones have the lowest concentration.
Most of the copper present in the plasma is firmly bound to alpha-2-glob- 
ulin called ceruloplasmin which according to Markowitz (126) was dis­
covered first by Holmberg and Laurell. A small fraction, about 5 per
cent is bound to albumin. This copper protein complex acts as an oxi­
dase upon many substrates such as serotonin, ascorbic acid and other 
polyphenols. Other enzymes activated by copper are uricase, and tyrosi­
nase (194) and monoamine oxidase. Red blood cells also contain a copper 
protein that was called Markowitz "erythrocuprein" (126). Cartwright 
(30) believes that copper is involved in myelination of nervous tissue
and the maintainance of normal skin pigmentation. Carres, £t (28)
and O'Dell (137) postulate that copper-deficient animals have defects 
of vascular integrity ascribable to abnormalities in the biogenesis of 
elastin. Its action in erythropoiesis is probably due to the increased 
absorption of iron and its incorporation into protoporphyrin in the form­
ation of heme (194).
The average amount of copper ingested daily by an adult is about
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2.5-5.0 mg, 99 per cent of which appears in-the stool, and the majority 
of that portion absorbed is excreted via the bile. About 70 pg appear 
in the urine per day (194).
Manganese
Cotzias (35, 36) has contributed a great deal to our understand­
ing of manganese absorpiton, excretion, turnover and excess. Ingested 
divalent manganese remains unchanged in the acid stomach, but as soon as 
it gets to the small intestine it becomes oxidized since alkaline condi­
tions are more favorable for oxidation. Intestinal absorption, like that 
of iron depends a great deal on the body pool. After it is absorbed, it 
is transported to the liver where it is conjugated with bile and then is 
excreted into the intestine. Manganese absorbed is transported via 
globulin plasma transmanganin, the trivalent form (35).
Britton and Cotzias (20) and Borg and Cotzias (14) have demon­
strated the dependence of manganese turnover upon supply. They suggested 
that disorders due to manganese deficiency or excess may result from slow 
or rapid rates of turnover. Hedge, e^ aĵ. (74) have demonstrated that 
serum concentrations of manganese are almost universally elevated after 
acute coronary occlusion. Rubenstein, et al. (155) reported an unusual 
case of diabetes mellitus that responded to the hypoglycemic effect of 
the plant extract infusion of alfalfa due to the high content of mangan­
ese (45.5 ug/kg).
Recently, however, Everson and Shrader (52) reported an impair­
ment of glucose tolerance and utilization in young adult guinea pigs de­
ficient in manganese. Other effects were also noted in manganese defi­
ciency such as skeletal defects including shortening of the leg bones.
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enlargement and malformation of joints and abnormalities in the shape of 
the skull (52). Hurley (83) and Hurley, £t (84) studied maternal 
dietary deficiency of manganese during pregnancy. They found irrevers­
ible congenital ataxia in the offspring of rats, mice and guinea pigs 
characterized by abnormal body rightly reflexes and mobility of the ani­
mal to orient itself in water. Supplementing with manganese during ges­
tation completely prevented the development of these abnormalities.
Alterations in Trace Metal Homeostasis in Hepatic Dysfunction 
Due to Ethanol and Other Hepatotoxic Agents
Vallee's discovery (197) of ADH, a zinc metalloenzyme from 
horse liver containing 2 g atoms of zinc per mole of protein and his sub­
sequent report of a conditional zinc deficiency in Laennec's syndrome 
(199) led many workers in this field to explore further the effect of 
alcohol and other hepatotoxic agents on the mobility of trace metals and 
electrolytes.
Sullivan, e^ (181) found 68 per cent of the cirrhotics and 
21 per cent of other hospitalized patients with serum zinc level 3 stan­
dard deviations below the normal mean. They also found low magnesium 
and calcium levels in serum of cirrhotics independent of zinc concentra­
tion. Concomitant with this were a high urinary zinc and magnesium ex­
cretion and an abnormally low serum albumin and Ug-globulin. In a sepa­
rate study (180), abnormal zincuria was transient, disappearing within 
two weeks in 80 per cent of those studied.
However, zinc excretion was not significantly changed when nor­
mal individuals ingested the alcohol. Cirrhotics, whose urinary excretion 
of zinc was high, were not further affected by the infusion of alcohol
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(182).
Very recently, Boyett and Sullivan (17) demonstrated that low 
serum zinc in cirrhotics was a function of serum albumin concentration. 
Zinc, they found, was consistently bound to transferrin and Og-macroglobu- 
lin. On the other hand, Prasad and Oberleas (151) presented evidence 
that amino acids are capable of binding zinc, hence the increased urin­
ary excretion associated with the aminoaciduria in cirrhotic patients.
Oppenheimer, ejt (139) studied the zinc content of horse 
liver alcohol dehydrogenase and found that the specific activity of LADH 
decreases as zinc is removed from the enzyme even when the sulfhydryl 
groups remain intact. However, there was a linear relationship between 
LADH zinc content and the stoichiometry of co-enzyme binding.
Vallee (200) hypothesized that the alcohol dehydrogenase of 
liver is vulnerable to repeated or to continuous metabolic insults by 
high concentrations of ethanol, thus causing a higher dynamic tissue 
ethanol level and the inability of liver cells to oxidize it after a cer­
tain threshold value. This is coupled with alterations of the protein 
structure of this enzyme whose degradation can lead to the observed amino 
acid and zinc excretion reported earlier (151, 180).
Hyperzincuria and hypozincemia in cirrhotics have been repeatedly 
confirmed by other workers (92, 149, 181) as well as the low level of 
liver zinc (218).
In spite of all these reports on cirrhotic patients, there is 
still doubt as to the value of this hyperzincuria as a diagnostic tool 
in ambulatory persons with chronic alcoholism (76) since the metabolic 
changes manifest themselves only in advanced stages of the disease.
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Doubts have also been voiced by Spry and Piper (177) relating abnormali­
ties of zinc concentration without knowing the iron status in the body. 
They stipulated that iron and zinc are absorbed by different metabolic 
pathways and that there is an increased turnover of zinc in the iron- 
deficient rats possibly related to the short-life span and increased zinc 
concentrate of iron-deficient rat red blood cells.
As for the decreased zinc level of cirrhotic liver, doubts have 
also been raised as whether this is due to a change in the chemical com­
position of liver cells or whether it may simply reflect the replacement 
of normal liver cells by connective tissue which have been shown to have 
low content of trace metals (187).
In order to determine whether the biochemical changes are due 
to the pathological changes caused by alcohol per se or some other se­
condary effects, Moses (132) administered ethanol to rats for 28 weeks 
and measured urinary iron, copper, magnesium and zinc. He found negative 
zinc balance in the ethanol treated rats, slightly increased liver zinc, 
lower liver and bone iron and no change in copper and magnesium. Barak, 
et al. (4) investigated the zinc pattern in cirrhotic rats put on a 
choline deficient diet versus rats fed alcohol only. In the former group 
there was a deficiency of zinc while in the latter group liver manganese 
was low.
As mentioned under experimental liver cirrhosis, several workers 
used hepatotoxic agents to produce damage in the liver cells as a model 
for studying trace metal kinetics. Kahn and Ozeran (93) injected rats 
intraperitoneally with 10 per cent carbon tetrachloride to produce liver 
cirrhosis. They found significant decrease in the liver and serum zinc
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level after five weeks of treatment. Saldeen and Brunk (162) damaged 
the liver of mice with 0.01 ml carbon tetrachloride to study the alkaline 
phosphatase distribution in the liver cells. They found a marked increase 
centrally in the biliary capillaries and in the cytoplasm and a moderate 
increase in the peripheral lobule of the liver. The increase was less 
pronounced when zinc was given in conjunction with carbon tetrachloride.
In a similar experiment, Saldeen and Stenrum (163) gave radioactive zinc 
along with carbon tetrachloride and found that livers of animals that re­
ceived ZnClg and carbon tetrachloride showed higher radioactivity than 
controls not receiving carbon tetrachloride showing a great demand for 
zinc uptake in damaged cells particularly the parenchymal rather than 
the Kupfer cells.
In order to correct this deficiency and reverse the pathological 
changes caused by these hepatotoxic agents, several workers tried admini­
stration of trace metals. Vallee, e^ (199) used oral ZnSO^ in doses 
of 19.5 pg/day in cirrhotic patients and claimed a significant improve­
ment. Surprisingly, subsequent to these plausible findings, ZnSO^ has 
never been used on a large scale in cirrhotic patients. Galakhova (65) 
gave ZnSO^ to rats poisoned with carbon tetrachloride. Total lipids and 
phospholipids increased in the cirrhotic liver but failed to disappear 
with subcutaneous injection of the ZnSO^. Fodor, e^ (57) pretreated 
cirrhotic livers with selenium and claimed a partial protection against 
the carbon tetrachloride-induced liver damage. Voinar, et al. (202) pre­
treated rats with MnClg and were able to alter the pathological changes 
induced by carbon tetrachloride. Kelomiitseva (98) gave rabbits CuSO^ 
and KI along with carbon tetrachloride. Pretreated rabbits showed more
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normal liver histology.
As mentioned earlier, attempts have been made to explain the 
effect of zinc deficiency at the cellular level. Sandstead, ^  al. (164) 
demonstrated a decrease in thymidine incorporation in vivo into the 
nuclear DNA in dietary zinc deficiency. This phenomenon was reversed 
rapidly with a single injection of zinc. Christophersen (32) suggested 
that ethanol increases the oxidation of the g-hydroxybutyrate by facili­
tating its transport into the mitochondria.
Cation transport and electrolyte excretion have also been ex­
plored extensively by many workers during ethanol intoxication (95, 118, 
179). Beard, ejt (6) presented data to indicate a retention of water, 
Na, K and Cl particularly in the animals receiving the higher doses of 
ethanol. He concluded that ethanol is capable of producing marked fluid 
alteration and electrolyte retention in the dog. Kalbfleisch, et al.
(95) induced an acute urinary diuresis of magnesium, calcium and a de­
creased K excretion during ethanol administration to normal and alcoholic 
subjects. They stipulated that the increased magnesium excretion was 
not due to changes in renal blood flow or glomerular filtration.
Lindeman (118) and Lindeman, et al. (117) observed magnesium deficiency 
in alcoholics. They reported increases in urine calcium and magnesium 
and a decreased urine potassium during acute ethanol ingestion. Sub­
stances such as glucose, galactose, fructose, casein, insulin and vaso­
pressin had similar effects (118).
They postulated that the increased glucose uptake and glycolysis 
block divalent cation reabsorption and potassium secretion in the distal 
tubule of the nephron.
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Kalant, (94), after ethanol treatment in the rat, found
a fall in the water content of the blood and a rise in K. Plasma K and 
Na fell down. Tissues showed a rise in intracellular water and Na and 
a fall in intracellular K, thus confirming the work of Beard, ^  (6).
Knutsson and Katz (103) stipulated that ethanol might increase Na perme­
ability of the membrane although at low concentration, ethanol had no 
effect on K membrane permeability.
Isreal-Jacard and Kallant (87) and Isreal, et (88) confirmed 
these reports by using guinea pig brain cortex slices. Initially they 
found no loss of K in these tissues, although it subsequently inhibited 
to a significant degree the reaccumulation of K.
CHAPTER III 
PURPOSE AND SCOPE
There seems to be a widespread belief among many workers in this 
field that metabolic aberrations and impairment of the liver function may 
explain some of the sequelae of alcohol addiction, which in turn leads to 
disturbance of the endocrine system such as the hypofunction of the ad­
renal cortex and the pituitary gland. The dichotomy between those who 
hold to the belief that alcohol addiction and its sequalae of hepatic 
dysfunction is genetic in origin versus those who offer an explanation 
based on epidemiological studies of culture and social patterns as well 
as diet habits seems to be widening as we learn more and more about the 
metabolic pathways of alcohol.
The reports on dietary deficiency of vitamins and trace elements 
are very conflicting as indicated heretofore. Although Vallee's work 
(199) has been confirmed repeatedly (93), zinc as a therapeutic agent 
has not come into wide use in alcoholic wards among cirrhotic patients.
We have used carbon tetrachloride in this investigation as a model for 
inducing cirrhosis of the liver in the rat in order to explore several 
parameters of trace metal kinetics. Since cirrhosis has not been success­
fully produced in the rat with the use of ethanol we used it, to compare 
the trace metal "shift" in non-cirrhotic rats with those that became
cirrhotic due to carbon tetrachloride.
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One of the major aims of this research project is to test the 
hypothesis proposed earlier as to whether cirrhosis is a conditioned zinc 
deficiency or some other trace metal deficiency. Although zinc has been 
explored extensively in the liver, urine and sera of the cirrhotics, 
little has been done to study the kinetics of other essential minerals 
in tissues other than liver.
We have undertaken this investigation, therefore to answer five 
important questions:
1. Is trace metal alteration of magnesium, iron, copper, manganese, 
and zinc of the same magnitude and in the same direction in the 
cirrhotic rat as in the alcoholic under similar experimental 
conditions?
2. In which of the organs, heart, kidney and liver are the changes 
most prominent?
3. Are there any correlations between changes in the total urine 
output per certain time with organ changes of magnesium, iron, 
copper, manganese and zinc?
4. What is the pattern of change in time as experimental conditions 
continue to be applied?
5. Can the administration of zinc alone ameliorate the pathological 
changes in the liver or affect the distribution or excretion of 
the other essential minerals?
Due to the controversy surrounding the value of zinc as a thera­
peutic agent in post-alcoholic cirrhosis, it would be of interest to test 
this hypothesis and to extend the study further to shed some light on 
changes in other vital metals which may be equally important as zinc in
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the metabolism of alcohol. Furthermore, a correlation between electro­
lyte changes in the urine and serum with that of the essential metals in 
the cirrhotic and alcoholic has not been described in the literature 
although scanty information indicates the inhibitory effect of ethanol 
on the active transport of cations across cell membrane (94). The pre­
sent investigation, therefore, was undertaken with the hope of resolving 
some of these apparent contradictions.
CHAPTER IV 
EQUIPMENT, METHODS AND PROCEDURE
Forty-eight adult female Holtzman albino rats purchased from 
Hormone Assay Laboratories, Chicago were received at our laboratories 
with ample supply of water and food before they were randomly divided 
into groups. They were weighed at the time they were received and every 
week thereafter until the end of the experiment. Their body weight at 
this time ranged between 100-125 grams.
After each rat was weighed, it was housed in an individual plas­
tic cage especially designed for metabolic studies. Feces and urine were 
separated on an inverted polyethylene funnel in which several holes were 
made. The round plastic cage was placed on top of a funnel of the same 
diameter. The bottom was made of glass rods spaced to allow feces and 
urine to pass through. At the lower end of the funnel neck was placed a 
small piece of glass wool to catch any food particles or fecal material 
that happened to escape. Extreme care was taken to assure proper separa­
tion with minimal contact of feces and urine.
All rats were supplied with tap water and ground Rockland rat- 
mouse pellets ad libitum. The tap water was replaced with deionized 
water at the initiation of the experiment. After the rats were acclima­
tized to the laboratory environment at a fairly constant temperature of 
72 12°C, they were randomly divided into six groups of eight rats each.
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The treatment each group received was as outlined below:
Group I - Intraperitoneal injections of 0.15 ml per 100 g of body
weight of 40 per cent carbon tetrachloride in olive oil.
Group II - Intraperitoneal injections of 0.6 ml per 100 g body weight
of 40 per cent ethanol in physiological saline.
Group III - Control which received intraperitoneal injections of 
saline.
Group IV - Same as group I except that in addition to the carbon 
tetrachloride they also received zinc solution as zinc 
chloride in saline intraperitoneally at the rate of 100 
Pg zinc per 100 g body weight.
Group V - Same as group II except that they were zinc supplemented
at the same rate as group IV.
Group VI - Received saline and zinc supplemented injections.
Zinc solution was prepared from a certified atomic absorption 
standard of 10,000 ppm solution in dilute nitric acid as solvent. Con­
centration of stock solution that was injected in the rats was 400 pg per 
100 ml. Injection of all groups was made on the average of three times 
a week, Monday, Wednesday, and Friday for ten consecutive weeks. Although 
initially they were started on four injections per week, the death of two 
rats from group I and group IV in the first two weeks made it necessary 
to curtail injections to three times a week. The dead ones were replaced 
immediately with rats from the same batch which were started on the same 
treatment as their respective groups.
Collection of Urine 
Urine was collected daily on each rat in a 25 ml polyethylene
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vial and was pooled into a 250 ml plastic bottle to which was added 0.5 
ml acetic acid as preservative. All plastic bottles were kept in the 
refrigerator except during the time of collection. At 2 , 4, 6, 8 and 10 
weeks of treatment the urine volume was filtered through glass wool and 
measured to the nearest milliliter. Three aliquots were collected in 
plastic vials. One aliquot was for the analysis of magnesium, iron, 
copper, manganese and zinc; another, for sodium, potassium and blood 
urea nitrogen analyses; and a third aliquot was placed in the freezer 
for further study.
At the end of four weeks of treatment, and at two weeks there­
after, two rats of each group were randomly chosen to be sacrificed.
Each rat was anesthetized by an intraperitoneal injection of sodium 
pentobarbital at the rate of 30 mg per kg of body weight. After an in­
cision was made through the thoraco-abdominal region, a needle of gauge 
20 attached to a 10 ml plastic syringe was inserted into the ventricle 
of the heart and blood was collected without any anticoagulant. Blood 
volumes obtained this way ranged between 4 ml.and 7 ml on each rat. 
Immediately after collection, blood was squeezed out carefully into a 
plastic cnetrifuge tube, left to coagulate and then centrifuged once to 
obtain the serum which was pipetted into a polyethylene vial and then 
stored in the refrigerator until the time of analysis.
Organs were obtained consistently in a similar fashion in order 
to avoid any changes due to surgical manipulation and hence changes in 
wet organ weight. The heart was excised right above the auricles, 
blotted well of blood; placed in a plastic vial and stored in the refrig­
erator for analysis. The liver was carefully separated from connective
60
tissue, placed on a parafilm and three thin sections were sliced off with 
a stainless steel blade. Two of them went into a 10 per cent formalin 
for histopathological examination of eosin and hematoxylin stain prepara­
tion and the third one into the deep freeze for oil red fat stain. The 
sections were consistently obtained from the upper left lobe to avoid 
intrahepatic variability. The kidneys were cleaned of fat tissue and 
stored away in the refrigerator. All vials were weighed before and after 
organs were placed in them. The difference between the two weights was 
considered to be the wet weight. Extreme precaution was taken at every 
step to insure minimum contact of the sample with contaminated objects. 
All glassware containers were acid washed and all plastic vials were used 
only once.
Trace Metal Analysis 
Liver, kidney, heart, urine and serum were analyzed for magnes­
ium, iron, copper, manganese and zinc by atomic absorption spectrophoto­
metry using the Perkin-Elmer atomic absorption spectrophotometer. Model 
303 to which is attached a Digital Concentration Readout (DCR) which 
provides some means of averaging the signal. The DCR can display on an 
illuminated readout either sample concentration or absorbance readings, 
approximately every two seconds or maintain a leading indefinitely. We 
have used the scale expansion feature of the DCR which enabled us to make 
the readout display the concentration value of the sample instead of the 
absorbance. In addition to that we have utilized the correction feature 
of the non-linearity in the working curve. These added features of the 
303 Perkin-Elmer atomic absorption did not only speed up the analysis of 
the large number of samples we have, but also made it possible to recheck
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the readout concentration of the standards every other fifth sample to 
make sure that the instrument parameters were consistent throughout the 
daily run. Furthermore, this digital voltmeter had a significant im­
provement upon the ordinary limits of precision and detection.
Since the Perkin-Elmer Atomic Absorption Spectrophotometer 
Model 303 is a double beam system, Table 1 is presented to illustrate 
instrumental specifications.
TABLE 1
SPECIFICATIONS OF INSTRUMENTAL CONDITIONS 
FOR ATOMIC ABSORPTION
Photometer: Double-beam system with a single detector 
shared in time by both beams; A-C output.
Monochromator : Czerny-Turner grating with dispersion of 
6.5A per mm in the UV region and 13.OA 
in the visible.
Wave Length Range: 1950 A - 8521 A
Resolution: 0.5 A in the UV and 1.0 A in the visible.
Readout: Counter readout in per cent absorption 
at scale control setting of 1. Scale 
expansion of IX, 2X, 5X, and lOX is avail­
able .
Optical System
As illustrated in Figure 3, the chopper which is a two segment 
rotating mirror with an open area between each segment creates a sample 
beam to M^ and a reference beam to Mg both modulated at 60 cycles per 
second. After the two beams are combined, they are focused on the en­
trance slit of the monochromator and then collimated by spherical mirror
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Fig. 3— Schematic diagram of the double-beam optical system of Perkin-Elmer AA Model 303.
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which has a focal length of 400 mm. The beam is then directed to 
either of the two diffraction gratings, depending upon the setting of 
range controlr The image formed on the exit slit is picked up by the 
photomultiplier detector which is located just behind exit slit.
Sample Preparations 
Urine and serum were aspirated directly into the flame using a 
premix burner whose sample uptake was approximately 5 ml per minute. The 
oxidizing flame was made up of compressed air at 25 psi pressure and 
acetylene at a pressure of 8 psi. The tissues were dried in an oven at 
110-115C in pyrex boats for 24 hours. No attempt was made to weigh the 
tissues after they were dried. From previous experience, it was felt 
that this was sufficient to get rid of most of the water and any small 
residue left would have been taken care of by the 24 hour period of sub­
sequent ashing. Furthermore, tissue concentration of metals was expressed 
in terms of either pg per gram tissue ash or grams per 100 gram tissue 
ash, hence dry values were not necessary.
Ashing was done in a Tracerlab Low Temperature Asher (Model 600) 
for a period of 24 hours. This technique is relatively new and has the 
advantage of retaining most of the volatile elements in the ashed sample. 
Oxidation of the organic materials for each sample takes place in a 
closed system at low temperature which does not exceed 150^0. By virtue 
of the fact that the system utilizes streams of molecular oxygen which 
passes through an electromagnetic field of electrodeless-radio-frequency, 
the absorbed energy creates activated oxygen atoms which break the mole­
cular bonds of the organic constituents of the sample and thus produce 
gaseous oxides such as COg, H^O and SO^ which are removed from the system
64
by a vacuum pump. The chambers were maintained at an oxygen flow of 70cc 
per minute and a vacuum of 1 mm of mercury. The radio-frequency forward 
power was operated at 250 watts with minimum reflected power.
It is well known that different tissues ash differently and 
hence require different lengths of time for complete ashing. In order 
to be consistent throughout the ashing procedure an equal time of 24 hours 
was alioted for each of the kidney, liver and heart tissues. This is 
three-fold the length of time recommended by the manufacturers.
Ashed tissues were collected directly from the pyrex boats into 
a weighed polyethylene vial. Only weighing paper was used to transfer 
the ash. Extreme care was taken to scrap the ashed sample well and mini­
mize the small fraction left in the boat. The difference in weight be­
tween the empty vial and the vial with sample gave us the ash weight of 
the sample which was carried to one hundred thousandth of a gram.
To dissolve the ash, 0.10 ml of 6 N HCl was added to each 10 mg 
of ash. The vial was shaken and left overnight. Just prior to analysis 
the dissolved ash was then diluted 1:10 so that the final normality of 
the HCl was 0.60. Subsequent dilutions were made in 0.6 N HCl and this 
depended on metal concentration of that particular tissue. Manganese 
needed no further dilution in any of the organs. For copper, zinc and 
iron of the heart and kidney, a ten-fold dilution was necessary. In the 
liver a twenty-fold dilution was needed for these metals. For magnesium 
in all three tissues, one hundred-fold dilution was made in order to come 
within the range of instrumental sensitivity.
Method of Analysis 
When all samples of every consecutive batch of urine, serum and
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tissues were ready to be analyzed, a set of standard solutions was pre­
pared fresh for each of the metals. For copper, manganese, iron and 
zinc in tissues a certified atomic absorption standard solution of 1000 
ppm each were diluted with 0.6 N HCl to obtain a concentration of 40 ppm 
stock solution from which 0.8, 1.20, 1.60 ppm working standards were pre­
pared for copper, manganese and zinc. Since sensitivity for iron was 
not as good, a higher concentration of working standards of 1.6, 3.2 and 
6.4 ppm were prepared. The commercial standard solutions obtained from 
Fisher Scientific Company, Fairlawn, New Jersey were checked against a 
laboratory prepared Specpure salt solution.
For magnesium determination, a 10,000 ppm stock solution was 
serially diluted in a similar fashion to contain 0.04, 0.08 and 0.12 
mEq/1. For sodium, potassium and blood urea nitrogen, samples were sent 
to the Renal Division laboratories of the Veterans Administration Hos­
pital for analysis. Flame emmission was used for sodium and potassium 
and the Auto-Analyzer was utilized for the determination of blood urea 
nitrogen.
A working curve was prepared for each of the metals. Correction 
for non-linearity was switched on all the time during the analysis. 
Working standards were checked every fifth sample and the concentration 
readout on the illuminated DCR panel was recorded.
Instrumental settings for each particular metal were optimized 
and a warm-up period was allowed for the whole system to stabilize. The 
hollow cathode tube current for each metal was set according to the manu­
facturers recommendations as follows. Magnesium 6 ma, iron 40 ma, copper 
15 ma, manganese 15 ma and zinc 15 ma. The corresponding reasonance line
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for each metal was 2852 A, 2483 A, 3247 A ,  2794.8 A and 2138 A, respec­
tively.
Data were collected and analyzed statistically at the Computer 
Facility to seek differences among groups for trace metal concentrations 
as well as the corresponding pathological changes in the liver. Analysis 
of variance, range, mean, standard deviation and F ratio were computed 
at the statistical significance of 5 per cent level. Data are tabulated 
in Appendix I for our published work on Tissue Trace Metal in Disease 
(216), in Appendix II on Decreased Zinc and Copper Content of Arterio­
sclerotic Aortas which was also published in -Clinical Research (217) and 




Pathological Alterations of Liver Tissue 
and Body Weight Changes
Success of this investigation has depended largely on the ease 
and speed of producing a pathological trauma in the liver or cirrhotic 
changes in order that the comparison of trace metal kinetics between 
cirrhotic and non-cirrhotic rats can be made. Fortunately our model 
system of carbon tetrachloride-induced cirrhosis which has been previously 
described was 100 per cent effective in altering liver cell architecture 
within four weeks of treatment.
As can be seen in Figures 4-6 a hematoxylin-eosine stain of 
liver sections are presented for the unsupplemented groups after eight 
weeks of treatment. Loss of liver cell architecture has been consis­
tently seen in all the carbon tetrachloride treated rats except for the 
one that died before sacrifice (Figure 4). Furthermore, ascites was a 
prominent feature of most of these rats. Summary of the complete histo­
logical examination of liver sections is presented in Appendix III,
Tables 7 and 8. In none of the rats that received alcohol were there 
any pathological changes except for occasional fatty infiltration which 
was confirmed with Oil Red 0 fat stain.
Figures 7-9 illustrate the pathological changes in the zinc
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Fig. 4— Carbon tetrachloride induced cirrhosis with loss of 
liver architecture, pseudolobule formation by fibrous tissue, enlarge­
ment of some liver cells and hyperchromatic nuclei.
Fig. 5— Normal liver architecture of alcohol treated rats.
Fig. 6— Normal liver of control group.
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HEMATOXYLIN AND EOSIN STAIN OF UNSUPPLEMENTED 







Fig. 7— Carbon tetrachloride treated liver with zinc supplemen­
tation. Histological examination reveals loss of liver architecture, 
fibrosis around the pseudolobules and fatty infiltration.
Fig. 8— Normal liver architecture of alcohol treated and zinc 
supplemented rats.
Fig. 9— Normal liver of control group.
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HEM ATOXYLIN A N D  EOSIN STAIN OF Z IN C  SUPPLEMENTED 
RAT LIVER TISSUE AFTER EIGHT WEEKS OF TREATMENT
Fig. 7




supplemented group. There was no substantial improvement of the liver 
cell architecture as seen in Figure 7. This can lead us to the conclu­
sion that under the present set of conditions described in this investi­
gation optimal zinc supplementation of 1.0 mg/kg body weight does not 
appear to reverse the pathological trauma caused by carbon tetrachloride. 
It must be remembered, however, that the duration of the experiment was 
much too short, if an analogy was to be made between human cirrhosis 
which was claimed to be corrected by zinc and rat cirrhosis induced with 
carbon tetrachloride.
In order to assess the relative healthy conditions of the six 
groups. Figures 10 and 11 are presented to show the body weight gains 
at weekly intervals for unsupplemented and zinc supplemented groups re­
spectively. Rats treated with carbon tetrachloride were slower in gain­
ing weight during the course of the experiment than either alcohol 
treated or control groups. This was in spite of the ascitic conditions 
which most of these rats developed.
"Shifts", in Trace Metal Patterns 
In an attempt to elucidate differences in trace metal patterns 
between carbon tetrachloride induced cirrhosis and chronic alcoholics 
without hepatic dysfunction, rat liver, heart and kidney as well as 
urine and sera were analyzed for five essential metals: magnesium, iron, 
manganese, copper and zinc. A comparison.of the relative degree of metal 
kinetics and its interorgan mobility was made between those that were 
zinc-supplemented and those that were not supplemented under exactly 
similar experimental conditions.
In seeking statistically significant differences, data collected
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Fig. 11— Gains in body weights of Zn-supplemented rats.
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were analyzed for means, standard deviation, analysis of variance.and 
F ratios. Tabulations of the data for each metal in a particular organ 
or biological fluid are presented in Appendix III, Tables 9 through 36. 
Following each table is a corresponding bar graph (Figure 14 - Figure 34) 
to depict the intragroup changes as well as the variations displayed in 
time at 4, 6, 8 and 10 weeks of treatment. Bar graphs are not presented 
for serum and urine analyses. All significant differences at the 5 per 
cent level or less are indicated with a superscript asterisk. Summary 
of statistically significant increases or decreases in the concentration 
of five metals in three organs, urine and sera of zinc supplemented as 
compared with unsupplemented rats is presented in Figure 12 and Figure 
13.
Heart Tissue - Zinc Supplemented vs. Unsupplemented Groups
Magnesiumg As can be seen in Figure 14, concentrations of mag­
nesium in the heart have increased uniformly in all six groups after ten 
weeks of treatment except in the fourth group which received zinc. Con­
versely, however, the first group which did not receive zinc has shown 
a consistently increasing concentration of magnesium in time although 
initially at four weeks of treatment, it was lower than the control values. 
In the unsupplemented groups, rats that received alcohol have maintained 
a higher concentration of cardiac tissue magnesium concentrations than 
control group in the same category. The over-all picture, then, seems 
to indicate that zinc supplementation helps maintain a level of magnesium 
in the. heart similar to that of the control while in the group receiving 
alcohol, magnesium concentration fell down in the first eight weeks of 
treatment but regained its value at the end of the tenth week.
H e a r t Kidney Liver
Unsupple. Zn supple. Unsupple. Zn supple Unsupple. Zn supple.
CCI4 EtOH CCI4 EtOH CCI4 EtOH CCI4 EtOH CCI4 EtOH C CI4 EtOH
Mg t Î 4 — 4 t
Fe * t t t 4 t 4 t — — --
Cu -- t — 4 t 4 t — t — 4 --
Mn t — * — t — t — --- 4 -- t
Zn — — — — — — -- — 4 t 4 —
(T\
Fig. 12— Significant changes in tissue metal concentrations.
Urine Serum
Two Weeks of Treatment FourWeeks of Treatment
Unsupple. Zn supple. Unsupple. Zn supple Unsupple. Zn supple.
CCI, EtOH CCI, EtOH CCI, EtOH CCI, EtOH CCI, EtOH C Cl, EtOH
Mg t t t Î -- t t t — t e
Fe — $ 4 4 4 4 4 4 4 4 4 4
Cu 4 t 4 t 4 t 4 — t
Mn 4 t — 4 — 4 — — — —
Zn t 4 t 4 t t t 4 — — — —
Na — 4 4 4 4 — 4 4 — — — —
K t 4 t t 4 4 4 4 — — 4 —
■««J
Fig. 13— Significant changes in urine and serum metal concentrations.
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Iron. In general, levels of iron were depressed in the rats 
that received carbon tetrachloride during the total course of the treat- 
mentwhile in those that were zinc supplemented, iron content of the heart 
tissue gradually decreased, but then increased significantly at the term­
ination of the experiment. In the unsupplemented group that received al­
cohol there was an initial increase in iron and then a leveling off to 
normal concentrations in subsequent weeks.
Copper. There was a statistically significant difference among 
the groups as well as in weeks of treatment. However, in both unsupple­
mented as well as zinc-supplemented carbon tetrachloride groups, levels 
of copper were kept virtually unchanged over time. In that of the alco­
hol groups, changes were inconsistent, although the trend as seen in 
Figure 16 points towards an increase in group two and a decrease in group 
five.
Manganese. Several different patterns of changes seem to have 
occurred in the manganese concentration of the heart tissue probably more 
so than with any other metal. There was an intra as well as an inter­
group variability which was highly significant, more markedly so in group 
one and four at the sixth and tenth week of treatment-. Manganese con­
centrations appear to have increased at least 40 per cent at the end of 
treatment with carbon tetrachloride whereas in the corresponding group 
that received zinc, manganese was initially high, but dropped to almost 
one-third of its value at the end of treatment. Groups that received 
alcohol did not change significantly from those of the control groups.
Zinc. No variability was noted among groups in the concentra­
tion of this metal, although there was an inconsistent change in the
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sixth week for group one and four. The change was of the same magnitude, 
but not unidirectional. As expected, zinc supplemented rats did not 
show any significant increase in cardiac zinc as compared to unsupple­
mented groups.
Kidney Tissue - Zinc-Supplemented vs. Unsupplemented Groups 
Magnesium. At six weeks of treatment, magnesium seems to be 
consistently diminished in all six groups. However, if an assumption 
is made that this may reflect a change in instrumental parameters for 
that particular period of time, then excluding this group would show a 
decrease in the carbon tetrachloride group and .in the alcohol treated 
group as compared to the control, and zinc supplementation would appear 
to have brought the concentration close to normal levels. The highly 
significant difference reflected in the F ratio for the weeks is re­
lated to the depressed values at the 6 week period.
Iron. Kinetics of this metal in the kidney appears to have 
been influenced by both carbon tetrachloride and ethanol, increasing in 
the former and diminishing in the latter. Zinc supplementation does not 
seem to have any significant effect on changing the iron pattern in the 
kidney. As can be seen in Table 15, intra and intergroup variability 
is highly significant with group one and group four having an F ratio 
of 6.17 and 4.85 respectively.
Copper. Alterations in the copper concentration of the kidney 
seem to follow the same pattern as that of iron. It was markedly and 
significantly increased in carbon tetrachloride treated rats in both 
unsupplemented and zinc-supplemented groups. Conversely, however, rats 
that received alcohol showed a decreased copper content in the kidney
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compared to the control groups. Zinc supplementation does not seem to 
change the magnitude of kidney copper levels.
Manganese. As can be seen in Figure 22, kidney manganese con­
centrations were similar to that of copper and iron. However, zinc sup­
plementation seems to increase its levels in the carbon tetrachloride 
group and to diminish it in the rats that received alcohol.
Zinc. The pattern of zinc concentration in the kidney appears
to be similar to that of magnesium, namely, depressed at the sixth week
of treatment in all groups but rising again on subsequent weeks. In 
general, zinc supplementation did not raise its concentration in the 
kidney as it might be expected in the carbon tetrachloride and ethanol 
treated rats probably due to the essentiality of this metal and the ne­
cessity of the body to conserve it, although in the zinc supplemented 
control group where conservation is less likely to be necessary, the 
zinc level has risen gradually, particularly at the end of the tenth 
week of treatment.
Liver Tissue
Magnesium. In all groups, magnesium levels were initially high, 
but after six weeks of treatment liver concentrations appear to have 
dropped and then gradually increased at eight and ten weeks of treatment. 
The average group concentration, however, remained low for group one and 
four compared to the control groups. Zinc supplemented groups seem to 
have retained more magnesium in the liver than unsupplemented ones.
Iron. Hepatic iron seemed to vary in time, increasing in all 
groups during the course of treatment. This is not an unexpected finding 
since growing rats do have a maximum sensitivity and larger requirement
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for essential metals such as iron. Nevertheless, the magnitude of this 
increase is much less frequent in the carbon tetrachloride and ethanol 
treated groups. The reciprocal relationship between iron and zinc does 
not seem to hold true here at least in the hepatic concentration, be­
cause it appears that the zinc supplemented control group has gained 
more iron than any other group. Since the liver is a large pool for 
iron storage it would not be surprising to find a great deal of vari­
ability.
Copper. In general, hepatic copper does not seem to have varied 
a great deal except in the fourth group where the average level was di­
minished in contrast to the control group. Whether this is due to zinc- 
supplementation which is believed to markedly decrease levels of hepatic 
copper or to the combined effect of carbon tetrachloride and zinc is not 
clear. It seems likely that there are similar, but as yet undefined, 
complex relationships between other metals. In contrast, however, un­
supplemented rats that received carbon tetrachloride had a highly signi­
ficant increase in hepatic copper at the end of the tenth week.
Manganese. No change could be observed in the hepatic mangan­
ese concentration neither in time nor among groups, although at the 
sixth week of treatment it was slightly depressed in group one and two.
Zinc. In view of the great attention that this metal has re­
ceived in the pathogenesis of liver disease, a more careful assessment 
of its role will be given here. It must be borne in mind, however, that 
the short course of treatment may not represent a true picture of a 
classical human cirrhosis that has been described elsewhere. Nonethe­
less, hepatic kinetics of this metal was quite variable. Intra group
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differences seem to be statistically significant reflecting a decrease 
in group one and group four if compared with their respective control 
groups. However, alcohol treated groups did not vary a great deal 
although there was a gradual increase in the unsupplemented in time and 
a steady leveling off in the zinc supplemented group. Groups two, three 
and six gained a substantial amount of zinc after ten weeks of treatment.
Changes in Wet and Ash Organ Weights
As can be seen in Table 24 there was no apparent difference in 
the heart wet weights between different groups neither was there a signi­
ficant difference in the ash weights. Computation of per cent ash weight 
as the ratio of wet weight to ash weight ranged between 1.06 and 1.34.
In view of the reports regarding involvement of alcohol with cardiomyo­
pathies it was expected that this would be reflected in cardiac wet 
weight. It is conceivable that changes in size of the heart would lay 
behind any alterations in essential metal kinetics.
In contrast, significant differences were found in kidney 
weights which were higher in carbon tetrachloride treated rats than con­
trol. In the zinc supplemented group, however, kidney weights were not 
significantly different than its corresponding control. There was no 
apparent change in the alcohol treated groups. Per cent ash kidney was 
on the average higher than that of the heart. It ranged between 1.18 - 
1.58 per cent.
Grossly the liver showed great variation in weight and texture 
in carbon tetrachloride treated rats, sometimes being small, at other 
times being large. For example, the wet weight was 13.5 g and 4.2 g 
after four weeks and eight weeks of treatment respectively. This would
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be anticipated since fibrous tissue accumulates in the early stages of 
the disease, but later when normal liver cells degenerate they are re­
placed with connective tissue. In spite of these obvious differences, 
the mean wet for each group as seen in Table 26 did not increase more 
than 15 per cent in the carbon tetrachloride and ethanol treated rats 
of the unsupplemented groups and 20 per cent in the zinc supplemented 
ones. As expected per cent ash weight of liver tissue was the highest.
It ranged between 1.35 - 2.35. It is apparent that this depends a great 
deal on the amount of connective tissue and hence on the treatment period 
at which the rat was sacrificed.
Trace metal values have been expressed in terms of concentra­
tions per ash weight; hence no attempt has been made to calculate for 
the total content of a metal in a particular organ. It was felt that 
this would be unnecessary since the study was intended to show compara­
tive concentrations rather than absolute values.
Urine
Since urine volume was pooled for each rat over a two week 
period, total output of each metal was computed for each group rather 
than concentrations. This would represent the true value of metal mo­
bility particularly in view of the significant differences in total 
urine output.
As illustrated in Table 31 total urine output was approximately 
twice as much in carbon tetrachloride treated rats as in the controls 
in unsupplemented as well as zinc supplemented groups. This difference 
was consistently so at four weeks of treatment as seen in Table 33 and 
on subsequent collections at 6, 8 and 10 weeks which is not shown in
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Appendix III. These latter collections were reduced by two urines every 
two weeks and hence a special statistical treatment is needed to evalu­
ate them, but a look at the raw data would seem to suggest the same 
trend on that of the first two collections.
Several different patterns of change in the total urinary out­
put of zinc, copper and manganese are observed at two (Table 31) and 
four (Table 33) weeks of treatment. It was not unexpected to see an in­
creased total output of zinc in the carbon tetrachloride treated rats in 
both unsupplemented as well as zinc supplemented groups, but it was sur­
prising to note a decrease in the alcohol treated rats in the correspond­
ing groups. Most surprising, however, was the unchanged pattern of 
urinary zinc output in the zinc supplemented groups at two weeks of 
treatment. Conversely, at four weeks of treatment, increased output of 
zinc is noted in both groups and zinc supplementation has brought the 
output of the three groups closer to one another.
In the carbon tetrachloride treated group after two weeks, 
copper output increased two-fold, manganese increased approximately 30 
per cent, iron remained unchanged, magnesium increased two-fold, potas­
sium increased slightly and sodium remained unchanged. After four weeks 
of treatment, the same pattern was noted except that manganese output 
increased further to approximately three-fold that of the normal, iron 
diminished 25 per cent, sodium diminished slightly and potassium remained 
unchanged.
In the zinc supplemented groups, magnesium, copper, manganese, 
zinc and potassium remained higher than normal, whereas iron and sodium 
were diminished.
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In the alcohol treated group, magnesium remained high, iron, 
copper and manganese were diminished at two and four weeks of treatment 
in both supplemented as well as zinc supplemented groups. Zinc output 
was diminished at two weeks of treatment, but was raised at four weeks 
of treatment in the unsupplemented group. Sodium and potassium were 
diminished or remained unchanged.
Serum
As can be seen in Figure 13 serum metal concentrations are not 
as variable as that of urine or tissues. It is hard to interpret the 
decreased concentrations of iron in all experimental groups due to the 
uncertainty of obtaining serum free of hemolysis. Copper and magnesium 
increases are interesting since they are in reciprocal relation to the 
hepatic concentrations, but in the same direction as that of the urine. 
Because of limitation of instrumental sensitivity as well as the insuffi­
cient aliquots of serum availability for analysis, manganese determina­
tion was not performed.
An unexpected finding in this investigation was the lack of 
change in serum zinc concentrations in unsupplemented as well as zinc 
supplemented groups. In view of the hypozincemia reported by Prasad 
(149) and Vallee (199), it is interesting to speculate as to whether the 
duration of the treatment was enough to produce hyperzincuria as reported 
above, but not enough to deplete the body stores particularly in blood 
serum which acts as a shuttle mechanism for all essential metals and 
hence the last pool to suffer the consequences of the depletion. In 
support of this view is the lack of increased zinc concentration in the 
supplemented groups as indicated in Figure 13.
CHAPTER VI
SUMMARY
A model system of carbon tetrachloride induced cirrhosis in the 
rat was used in this investigation to compare the relative degree of bio­
chemical alterations of five essential metals: magnesium, iron, copper, 
manganese and zinc. An analogous system of ethanol and administration 
which is known not to produce pathological changes in the rat liver was 
carried out to test the hypothesis as to whether the changes in trace 
metal kinetics in cirrhosis are due solely to the hepatic cellular de­
struction by carbon tetrachloride or increased cellular permeability 
caused by ethanol. Each system was run with or without zinc supplemen­
tation to test the degree of effectiveness with which zinc can alter the 
mobility of essential metals and/or reverse the biochemical insult in 
the liver of carbon tetrachloride infected rats. It must be emphasized, 
however, that the two systems tested were run under exactly similar ex­
perimental conditions. Each system of carbon tetrachloride and ethanol 
had its own control of saline and saline with zinc in the unsupplemented 
and zinc supplemented groups respectively.
Each of the six groups of eight rats received on the average 
three intraperitoneal injections per week for ten consecutive weeks.
Two rats of each group were sacrificed after four weeks of treatment and 
every consecutive two weeks thereafter.
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In the 2200 determinations made by atomic absorption spectro­
scopy on heart, kidney, liver, urine and serum, differences were sought 
between cirrhotic and non-cirrhotic on one hand and between unsupplemented 
and zinc supplemented on the other. Results of these findings are out­
lined below:
1. Histological examination of liver sections revealed loss of nor­
mal liver architecture, fibrosis and fatty infiltration in the 
carbon tetrachloride treated rats.
2. No pathological changes were noted in the alcohol treated rat 
livers supporting the thesis that rats are immune to alcoholic 
cirrhosis.
3. Zinc supplementation failed to reverse the pathological altera­
tions induced by carbon tetrachloride although it did change the 
distribution of some trace metals.
4. Urine output of carbon tetrachloride treated groups exceeded 
those of alcohol and control groups by two-fold. It is not 
known whether this is due to the large amount of water intake 
observed in these rats or to some other mechanism at the cellu­
lar level.
5. Trace metal pattern in the cardiac tissue was variable, but in 
general, magnesium increased in the unsupplemented groups, iron 
diminished but increased again on zinc supplementation, and zinc 
remained unchanged. Manganese increased in the carbon tetra­
chloride group, but reversed its direction on zinc supplementa­
tion. In contrast, copper increased in ethanol treated rats but 
was diminished on zinc supplementation.
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6. Alterations in the renal trace metal kinetics revealed signifi­
cant changes in iron and copper. There was no difference between 
unsupplemented and zinc supplemented groups. Both iron and cop­
per increased in carbon tetrachloride treated kidneys but dimin­
ished in ethanol treated groups.
7. In the hepatic tissue, variation was inconsistent. However, the 
general trend seems to indicate increased concentrations of mag­
nesium in the carbon tetrachloride group and increased zinc con­
centration in the ethanol treated ones. Copper increased, but 
was diminished on zinc supplementation. Manganese concentrations 
decreased in the carbon tetrachloride treated group.
8. Excretion rates of trace metals in the urine varied widely. In 
brief, magnesium remained high in both groups when compared to 
corresponding controls. In contrast, iron and sodium remained 
low in all test groups. Potassium, zinc, manganese and copper 
were variable, but in general they increased in carbon tetra­
chloride treated groups and diminished in the ethanol. Zinc 
supplementation did not change the pattern.
9. In the serum, variation was less striking than in the urine.
Iron diminished in both groups, unsupplemented and zinc supple­
mented, whereas magnesium and copper urinary output increased.
No significant alterations were noted in the total urinary zinc 
output.
10. It would appear from the aforementioned results that the clini­
cal manifestations seen in human cirrhosis could be related to 
shifts in the essential micronutrients of the liver other than
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zinc particularly copper and manganese. Further exploration on 
supplementation studies of these metals singly or in combination 
in the rats of our model system of carbon tetrachloride induced 
cirrhosis could provide some answers to the pathogenesis of liver 
disease and hence establish a rationale for treatment and ther­
apy in humans. Furthermore, the excretion pattern of proteina- 
ceous macromolecules in the urine in conjunction with trace 
metal concentrations could shed some light on the nature of the 
available binding sites and hence further our understanding of 
the sub-cellular pathology and etiology of this disease.
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APPENDIX I 
TISSUE TRACE METAL IN DISEASE*




CONCENTRATIONS IN MICROGRAMS PER GRAM ASH OF INDICATED 
METALS OF NORMAL AND CIRRHOTIC HUMAN LIVER, 
KIDNEY MEDULLA, KIDNEY CORTEX AND HEART
Tissue N Metal Normal Cirrhotic




Kidney 5 Cu 302 167
Medulla Mn 100 82
Sn 47 36
Ti 13.2 9.8
• V 2.0 0.24
Kidney 5 Fe 4,000 4,838
Cortex Mn 96 100
Heart 5 Zn 2,881 3,335
Only statistically significant differences are given for the
underlined values at the 5 per cent level.
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TABLE 3
CONCENTRATIONS IN MICROGRAMS PER GRAM ASH OF INDICATED 
METALS OF NORMAL AND BROCHOGENIC CARCINOMA 
OF HUMAN LIVER, KIDNEY MEDULLA,
KIDNEY CORTEX AND HEART
Tissue N • Metal Normal
Bronchogenic
Carcinoma




Kidney 5 Cu 302 264




Kidney 5 Fe 4,000 4,975
Cortex Mn 96 48
Heart 5 Zn 2,881 2,958
Only statistically significant differences are given for the
underlined values at the 5 per cent level.
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TABLE 4
CONCENTRATIONS IN MICROGRAMS PER GRAM ASH OF INDICATED 
METALS OF NORMAL AND MYOCARDIAL INFARCTION 
OF HUMAN LIVER, KIDNEY MEDULLA,
KIDNEY CORTEX AND HEART
Cardiac
Tissue N Metal Normal Infarction









Kidney 5 Fe 4,000 4,547
Cortex Mn 96 64
Heart 5 Zn 2,881 1,740
Only statistically significant differences are given for the 
underlined values at the 5 per cent level.
Ill
TABLE 5
CONCENTRATIONS IN MICROGRAMS PER GRAM ASH OF INDICATED 
METALS OF NORMAL AND HYPERTENSIVE 
OF HUMAN LIVER, KIDNEY MEDULLA,
KIDNEY CORTEX AND HEART
Tissue N Metal Normal Hypertension




Kidney 5 Cu 302 187




Kidney 5 Fe 4,000 5,534
Cortex Mn 96 50
Heart 5 Zn 2,881 3,508
Only statistically significant differences are given for the
underlined values at the 5 per cent level.
APPENDIX II
DECREASED ZINC AND COPPER OF ARTERIOSCLEROTIC AORTAS*




CONCENTRATIONS IN MICROGRAMS PER GRAM ASH OF INDICATED 




Dry «eight ^ 33.8 38.5 > 0.10wet weight
Ash weight ^ 2.8 6.1 < 0.001wet weight
Cu 234 64 < 0.001
Zn 1196 652 < 0.001
Fe 213 292 > 0.10
CO 1.47 2.27 > 0.10





SUMMARY OF THE PATHOLOGICAL FINDINGS IN THE 
UNSUPPLEMENTED RAT LIVERS (H&E STAIN)
Rat No. CC&4 Eton Saline
I Fatty infiltration. Young fibroblasts 
in between liver cells and portal area.
Normal Normal
2 Loss of liver architecture. Pseudo- 
lobule formation by fibrous tissue.
Some liver cells are enlarged. Contain 
hyperchromatic nuclei.
Normal Normal
3 Loss of normal liver architecture. 
Beginning of laying down of collagen 
by fibroblasts.
Normal Normal
4 Fatty infiltration Normal Normal
5 Fatty infiltration Normal Normal
6 Marked fatty infiltration. Fibroblasts 
in between liver cells. Loss of nor­
mal liver architecture.
Normal Normal
7 Autolysis Normal Normal
8 Loss of liver architecture. Hyper­





SUMMARY OF THE PATHOLOGICAL FINDINGS IN THE 
ZN-SUPPLEMENTED RAT LIVERS 
(H&E STAIN)
Rat No. CC&4 + Zn Eton + Zn Saline + Zn
1 Loss of normal liver architecture. 
Marked vacualiation of liver cells. 
Fibrosis. Pseudolobulation and 
bile duct proliferation.
Normal Normal
2 Autolysis Normal Normal
3 Loss of normal liver architecture. 
Fibrosis around the pseudolobules. 
Fatty infiltration.
Normal Normal
4 Marked fatty infiltration. Few 
fibroblasts in between liver cells.
Normal Normal
5 Fibroblasts in between liver cells. 
No fat.
Normal Normal
6 Fatty infiltration. Little 
fibrosis.
Normal Normal
7 Fatty infiltration. Some fibrosis. Normal Normal
8 Fibrosis with pseudolobule forma­




MAGNESIUM CONTENT OF HEART TISSUE
IN g/lOOg OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
Weeks
4 1.0970 1.5015 1.3680 1.5135 1.5590 1.4960
6 1.4435 1.5925 1.5045 1.6689 1.4800 1.5440
8 1.3980 1.4919 1.2795 1.5499 1.3435 1.4985
10 1.6105 . 1.7084 1.5835 1.5835 1.6869 1.7324
Analysis of Variance
SS DF MS F
Weeks 0.42 3 0.14 9.509*
Groups 0.26 5 5.28 3.567*
Groups
X
Weeks 0.25 15 1.66 1.122
Within
Cell 0.35 24 1.48
Simple Effect
Week within Groups
Groups SS DF MS F
1 0.27 3 9.15 6.17*
2 6.08 3 2.02 1.36
3 0.11 3 3.70 2.49
4 2.65 3 88.34 0.59
5 0.12 3 4.14 2.79
6 7.53 3 2.51 1.69
Group within Weeks
Weeks SS DF MS F
4 0.29 5 5.9 3.97*
6 6.71 5 1.3 0.90
8 0.10 5 2.1 1.45
10 4.40 5 87.9 0.59
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Fig. 14— Magnesium content of heart tissue.
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TABLE 10
IRON CONTENT OF HEART TISSUE
IN g/lOOg OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
Weeks
4 0.7200 1.1650 0.8050 0.8850 0.9900 0.8700
6 0.6550 0.9000 0.9350 0.7900 0.8549 0.9250
8 0.7400 0.7150 0.9100 0.6250 0.9599 0.7500
10 0.7050 0.8750 0.8050 1.3150 1.0250 0.9499
Analysis of Variance
SS DF MS F
Weeks 0.18 3 6.10 1.136
Groups 0.30 5 6.07 1.131
Groups
X
Weeks 0.66 15 4.41 0.821
Within
Cell 1.29 24 5.37
Simple Effect
Week within Groups
Group SS DF MS F
1 79 3 26 0.04
2 0.20 3 6.9 1.29
3 2.82 3 94.1 0.17
4 0.52 3 0.17 3.22*
5 0.32 3 1.07 0.20
6 4.75 3 1.58 0.29
Group within Weeks
Weeks SS DF MS F
4 0.24 5 4.82 0.89
6 0.11 5 2.26 0.42
8 0.16 5 3.19 0.59
10 0.45 5 9.01 1.67
^Significant at the 5 per cent level.
1 . 2 5
(O< 1.00 
o









G r o u p
U n s u p p l e m e n t e d
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Fig. 15— Iron content of heart tissue.
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TABLE 11
COPPER CONTENT OF HEART TISSUE
IN yg/g OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment C C ^ Ethanol Saline CC^l^ + Zn Ethanol + Zn Saline + Zn
Weeks
4 365 365 355 340 420 385
6 345 405 415 355 375 385
8 325 365 300 340 280 355
10 380 445 410 335 345 430
Analysis of Variance
SS DF MS F
Weeks 27816 3 9272 6.868*
Groups 17475 5 3495 2.588*
Groups
X
Weeks 28808 15 1920 1.422
Within
Cell 32400 24 13.50
Simple Effect
Week within Groups
Group SS DF MS F
1 3437 3 1145 0.84
2 8800 3 2533 2.17
3 17500 3 5833 4.32*
4 450 3 150 0.11
5 20700 3 6900 5.11*
6 5737 3 1912 1.41
Group within Weeks
Weeks SS DF MS F
4 7766 5 1553 1.15 .
6 7500 5 1500 1.11
8 10675 5 2135 1.58
10 20341 5 4068 3.01*
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Fig. 16— Copper content of heart tissue.
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TABLE 12
MANGANESE CONTENT OF HEART TISSUE





















3 4 5 
Saline CC&4 + Zn Ethanol + Zn
20.0 24.5 18.5










SS DF ■ MS F
Weeks 400 3 133 9.007*
Groups 583 5 116 7.866*
Groups
X
Weeks 1038 15 69 4.667*
Within
Cell 356 24 14.8
Simple Effect
Weeks within Groups
Group SS DF MS F
1 439 3 146 9.87*
2 56 3 18 1.26
3 51 3 17 1.15
4 762 3 254 17.13*
5 9 3 3 0.21
6 120 3 40 2.70
Group within Weeks
Weeks SS DF MS F
4 100 5 20 1.35
6 492 5 98 6.64*
8 67 5 13 0.90
10 961 5 192 12.95*
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Fig. 17— Manganese content of heart tissue.
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TABLE 13
ZINC CONTENT OF HEART TISSUE
IN yg/g OF TISSUE ASH
Group Means
Group' I 2 . 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 -f Zn Ethanol + Zn Saline + Zn
Weeks
4 1300 1330 1235 1300 1450 I3I0
6 1400 1495 1485 1675 1460 1420
8 II65 1325 II30 I3I5 1260 1265
10 1465 1505 1470 1470 1485 1495
Analysis- of Variance
SS DF MS F
Weeks 532508 3 177502 23.228*
Groups 84850 5 16970 2.220
Groups
X
Weeks 127366 15 8491 I. Ill
Within
Cell 183400 24 7641
Simple Effect
Week within Groups
Group SS DF MS F
I 102450 3 34150 4.46*
2 59637 3 19879 2.60
3 185300 3 61766 8.08*
4 182700 3 60900 7.96*
5 64337 3 21445 2.80
6 65450 3 2I8I6 2.85
Group within Weeks
Weeks SS DF MS F
4 50241 5 10048 1.31
6 96341 5 19268 2.52*
8 63066 5 I26I3 1.65
10 2566 5 513 0.06
*Signifleant at the 5 per cent level.
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Fig. 18— Zinc content of heart tissue.
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TABLE 14
MAGNESIUM CONTENT OF KIDNEY TISSUE
IN g/lOOg OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&, + Zn Ethanol + Zn Saline + Zn
Weeks
4 1.0394 1.2669 1.3500 1.3739 1.3710 1.3009
6 0.8209 0.8270 0.8755 0.8939 0.8360 0.9390
8 1.1370 1.2285 1.2340 1.1765 1.2645 1.2220
10 1.1280 1.0035 1.2525 1.0970 1.1735 1.3100
Analysis of Variance
SS DF MS F
Weeks 1.2 3 0.40 27.491
Groups 0.15 5 3.09 2.106
Groups
Weeks 0.17 15 1.13 0.768
Within
Cell 0.35 24 1.47
Simple Effect
Week within Groups
Group SS DF MS F
1 0.129 3 4.32 2.93
2 0.253 3 8.458 5.75*
3 0.259 3 8.651 5.88*
4 0.236 3 7.891 5.36*
5 0.321 3 0.107 7.28*
6 0.181 3 6.04 4.11*
Group within Weeks
Weeks SS DF MS F
4 0.160 5 3.215 2.18
6 2.129 5 42.588 0.28
8 2.095 5 41.930 0.28
10 0.121 5 2.428 1.65
^Significant at the 5 per cent level.
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Fig. 19— Magnesium content of kidney tissue.
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TABLE 15
IRON CONTENT OF KIDNEY TISSUE
IN g/IOOg OF TISSUE ASH
Group Means
Group I 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
Weeks
4 0.4849 0.3700 0.4150 0.3750 0.3200 0.4500
6 0.3700 0.2300 0.2500 0.5100 0.3550 0.3300
8 0.6100 0.3000 0.4700 0.4000 0.5700 0.4500
10 1.0700 0.3000 0.5350 0.9599 0.3549 0.6499
Analysis of Variance
SS DF MS F
Weeks 0.629 3 0.209 6.878*
Groups 0.571 5 0.II4 3.745*
Groups
Weeks 0.678 15 4.520 1.481
Within
Cell 0.732 24 3.050
Simple Effect
Week within Groups
Group SS DF MS F
I 0.565 3 0.188 6.17*
2 0.196 3 65.330 0.21
3 8.925 3 2.975 0.97
4 0.444 3 0.148 4.85*
5 7.870 3 2.623 0.85
6 O.IIO 3 3.674 1.20
Groups within Weeks
Weeks SS DF MS F
4 3.106 5 62.133 0.20
6 0.100 5 2.012 0.65
8 0.127 5 2.549 0.83
10 0.990 5 0.198 6.49















W e e k s  —
G r o u p  —
U n s u p p l e m e n t e d
4 6 8  10 4 6 8  10 4 6 8  10
1 2 3
Zn S u p p l e m e n t e d □  CCI4 
E3 EtOH 
WA Saline 
■  CCl 4 +Zn 
ESEtOH + Zn 
line +Zn
4 6 8  10 4 6 8  10 4 6 8  10
4 5 6
u>o
Fig. 20— Iron content of kidney tissue.
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TABLE 16
COPPER CONTENT OF KIDNEY TISSUE
IN yg/g OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
Weeks
4 375 265 340 465 455 390
6 270 150 235 350 175 280
8 610 225 345 375 270 330
10 345 210 315 415 230 355
Analysis of Variance
SS DF MS F
Weeks 134656 3 44885 5.885*
Groups 210785 5 42157 5.527*
Groups
Weeks 140256 15 9350 1.225
Within
Cell 183050 24 7627
Simple Effect
Week within Groups
Groups 129§So D| 43^§0 F5.65*
2 13650 3 4550 0.59
3 15537 3 5179 0.67
4 15137 3 5045 0.66
5 88450 3 2948 3.86*
6 12837 3 4279 0.56
Groups within Weeks
Weeks SS DF MS F
4 55566 5 11113 1.45
6 53766 5 10753 1.40
8 180341 5 36068 4.72*
10 61366 5 12273 1.60
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Fig. 21— Copper content of kidney tissue,
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TABLE 17
MANGANESE CONTENT OF KIDNEY TISSUE
IN lig/g OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn 1Ethanol + Zn Saline + Zn
Weeks
4 53.0 56.5 52.5 59.0 41.5 45.0
6 31.0 24.5 30.5 46.5 27.0 32.0
8 58.0 41.0 45.5 63.0 41.5 39.0
10 68.5 32.5 50.5 69.0 46.0 56.5
Analysis of Variance
SS DF MS F
Weeks 3492 3 1164 13.627*
Groups 2685 5 537.0 6.286*
Groups
X
Weeks 1323 15 88 1.033
Within
Cells 2050 24 85.4
Simple Effect
Week within Groups
Group SS DF MS F
1 149 3 499 5.84*
2 1124 3 374 4.38*
3 593 3 197 2.31
4 543 3 181 2.12
5 411 3 137 1.60
6 646 3 215 2.52
Group within Weeks
Weeks SS DF MS F
4 452 5 90 1.06
6 589 5 117 1.38
8 1007 5 201 2.35
10 1959 5 391 4.58*
^Significant at the 5 per cent level.
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Fig. 22— Manganese content of kidney tissue.
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TABLE 18
ZINC CONTENT OF KIDNEY TISSUE
IN yg/g OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CCJI4 Ethanol Saline CC&^ + Zn Ethanol + Zn Saline + Zi
Weeks
4 1150 1370 1375 1450 1410 1350
6 945 860 970 1055 950 1015
8 1235 1325 1350 1340 1455 1305
10 1315 1055 1455 1415 1305 1630
Analysis of Variance
SS DF MS F
Weeks 1328968 3 442996 14.860*
Groups 235710 5 47142 1.581
Groups
Weeks 335347 15 22356 0.749
Within
Cell 715450 24 29810
Simple Effect
Week within Groups
Group SS DF MS F
1 151937 3 51645 1.69
2 344250 3 114750 3.84*
3 280850 3 93616 3.14*
4 192900 3 64300 2.15
5 314100 3 104700 3.51*
6 380300 3 126766 4.25*
Group within Weeks
Weeks SS DF MS F
4 109241 5 21848 0.73
6 44541 5 8908 0.29
8 51300 5 10260 0.34
10 365975 5 73195 2.45
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Fig. 23— Zinc content of kidney tissue.
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TABLE 19
MAGNESIUM CONTENT OF LIVER TISSUE
IN g/lOOg OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CCA, + Zn Ethanol + Zn Saline + Zi
Weeks
4 1.2580 1.1124 1.1885 1.1400 1.1825 1.2000
6 0.7845 0.8815 0.9939 1.0240 1.0425 1.0810
8 1.0365 1.1124 1.1585 1.0855 1.3435 1.1730
10 1.1004 1.2405 1.2094 0.9275 1.2764 1.2735
Analysis of Variance
SS DF MS F
Weeks 0.364 3 0.121 6.251*
Groups 0.199 5 3.987 2.051
Groups
Weeks 0.249 15 1.666 0.857
Within
Cell 0.466 24 1.943
Simple Effect
Week within Groups
Group SS DF MS F
1 0.232 3 7.758 3.99*
2 0.134 3 4.472 2.30
3 5.763 3 1.921 0.98
4 4.982 3 1.660 0.85
5 0.102 3 3.403 1.75
6 3.795 3 1.265 0.65
Group within Weeks
Weeks SS DF MS F
4 2.543 5 50.873 0.26
6 0.126 5 2.531 1.30
8 0.112 5 2.259 1.16
10 0.184 5 3.688 1.89
*Significaiit at the 5 per cent level.
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Fig. 24— Magnésium content of liver tissue.
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TABLE 20
IRON CONTENT OF LIVER TISSUE 
IN g/lOOg OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
Weeks
4 1.2400 1.6100 1.7400 1.1400 1.4700 1.9599
6 0.9300 1.4199 1.9000 2.0800 1.2800 2.6200
8 1.6200 1.4400 2.3100 1.1699 1.9999 2.4100
10 1.9900 1.8300 2.9900 2.0800 2.5099 3.8300
Analysis of Variance
SS DF MS F
Weeks 7.085 3 2.361 9.814*
Groups 9.279 5 1.855 7.711*
Groups
Weeks 3.653 15 0.243 1.012
Within
Cell 5.775 24 0.240
Simple Effect
Week within Groups
Group SS DF MS F
1 1.269 3 0.423 1.75
2 0.217 3 7.233 0.30
3 1.865 3 0.621 2.58
4 1.171 3 0.570 2.37
5 1.844 3 0.615 2.55
6 3.829 3 1.276 5.30*
Groups within Weeks
Weeks SS DF MS F
4 0.950 5 0.190 0.78
6 3.756 5 0.751 3.12*
8 2.454 5 0.490 2.03
10 5.771 5 1.154 4.79*
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Fig. 25— Iron content of liver tissue.
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TABLE 21 
COPPER CONTENT OF LIVER TISSUE
IN yg/g OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&, + Zn Ethanol + Zn Saline + Zn
Weeks
4 380.0 460.0 430.0 320.0 470.0 450.0
6 230.0 380.0 450.0 390.0 440.0 480.0
8 540.0 380.0 380.0 350.0 450.0 390.0
10 540.0 430.0 410.0 280.0 430.0 520.0
Analysis of Variance
SS DF MS F
Weeks 9700 3 3233 0.233
Groups 76366 5 15273 1.104
Groups
Weeks 170700 15 113800 0.822
Within
Cell 332000 24 13833
Simple Effect
Week within Groups
Group SS DF MS F
1 132950 3 44316 3.20*
2 9350 3 3116 0.22
3 5350 3 1783 0.12
4 13000 3 4333 0.31
5 1750 3 583 0.04
6 18000 3 6000 0.43
Group within Weeks
Weeks SS DF MS F
4 33366 5 6673 0.48
6 79500 5 15900 1.14
8 48300 5 9660 0.69
10 85900 5 17180 1.24
*Signifleant at the 5 per cent level.
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Fig. 26— Copper content of liver tissue.
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TABLE 22
MANGANESE CONTENT CE LIVER TISSUE 
IN yg/g OF TISSUE ASH
. Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
Weeks
4 270.0 314.0 262.0 230.0 237.0 244.0
6 155.0 197.0 249.0 252.0 237.0 288.0
8 277.0 213.0 268.0 260.0 199.0 261.0
10 256.0 244.0 262.0 220.0 303.0 252.0
Analysis of Variance
SS DF MS F
Weeks 7416 3 2472 1.620
Groups 6804 5 1360 0.892
Groups
Weeks 40298 15 2686 1.761
Within
Cell 36600 24 1525
Simple Effect
Week within Groups
Group SS DF MS F
1 15748 3 5249 3.44*
2 16108 3 5369 3.52*
3 385 3 128 0.08
4 2086 3 695 0.45
5 11208 3 3736 2.44
6 2179 3 726 0.47
Group within Weeks
Weeks SS DF MS F
4 9407 5 1881 1.23
6 21942 5 4388 2.87*
8 8360 5 1672 1.09
10 7393 5 1478 0.96
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Fig. 27— Manganese content of liver tissue.
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TABLE 23
ZINC CONTENT OF LIVER TISSUE 
IN yg/g OF TISSUE ASH
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC^l^ + Zn Ethanol + Zn Saline + Zn
Weeks
4 3320 3150 2720 2700 3160 2760
6 2020 2560 2630 2650 3030 3110
8 2260 2870 2510 2410 3640 2860
10 2680 3850 3340 1940 3180 3830
Analysis of Variance
SS DF MS F
Weeks 1607633 3 535877 2.200
Groups 4540800 5 908160 3.728*
Groups
Weeks 5529266 15 368617 1.513
Within
Cell 5845200 24 243550
Simple Effect
Week within Groups
Group SS DF MS F
1 1946400 3 648800 2.66
2 1818550 3 606183 2.48
3 822000 3 274000 1.12
4 723400 3 241133 0.99
5 426950 3 142316 0.58
6 139960 3 466533 1.91
Groups within Weeks
Weeks SS DF MS F
4 74096 5 148193 0.60
6 1519460 5 303893 1.24
8 2462960 5 492593 2.02
10 5346660 5 1069330 4.39*
*Significant at the 5 per cent level.
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Fig. 28— Zinc content of liver tissue.
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TABLE 24
WET WEIGHT OF HEART TISSUE IN GRAMS
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
Weeks
4 0.7328 0.7160 0.8335 0.7445 0.7585 0.7173
6 0.8975 0.7716 0.7682 0.6741 0.7716 0.8080
8 0.6721 0.7478 0.8631 0.8110 0.8508 0.7141
10 0.8143 0.7733 0.7710 0.7168 0.7990 0.7727
Analysis of Variance
SS DF MS F
Weeks 70 3 23 0.258
Groups 3 5 63 0.700
Groups
X
Weeks 0.11 15 73 0.818
Within
Cell 0.21 24 90
Simple Effect
Weeks within Groups
Group SS DF MS F
1 6 3 1.9 2.13
2 43 3 14 0.15
3 1.3 3 44 0.49
4 2 3 66 0.73
5 1 3 33 0.37
6 1.2 3 41 0.45
Groups within Weeks
Weeks SS DF MS F
4 2 5 38 0.42
6 5 5 1.0 1.15
8 6 5 1.2 1.32
10 1 5 22 0.24
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Fig. 29— Wet weight of heart tissue.
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TABLE 25
WET WEIGHT OF KIDNEY TISSUE IN GRAMS
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
Weeks
4 1.7706 1.3302 1.7829 1.5671 1.7818 1.6018
6 2.1021 1.6563 1.7020 1.8888 1.7566 1.6795
8 1.8322 1.6889 1.7279 1.9715 1.8513 1.6955
10 2.6133 1.6808 1.6060 1.7686 1.6521 1.5360
Analysis of Variance
SS DF MS F
Weeks 0.23 3 8 3.611*
Groups 1.20 5 0.2 11.252*
Groups
X
Weeks 1.1 15 7 3.423*
Within
Cell 0.52 24 2.2
Simple Effect
Weeks within Groups
Group SS DF MS F
1 0.9 3 0.3 13.51*
2 0.2 3 6 2.75
3 3 3 1 0.50
4 0.2 3 6 2.83
5 4 3 1 0.62
6 3 3 1 0.50
Group within Weeks
Weeks SS DF MS F
4 0.3 5 6 2.94*
6 0.3 5 6 2.67*
8 0.1 5 2 1.12
10 2 5 0.3 14.77*
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Fig. 30— Wet weight of kidney tissue.
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TABLE 26
WET WEIGHT OF LIVER TISSUE IN GRAMS
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC£^ + Zn Ethanol + Zn Saline + Zn
Week
4 8.7620 6.5319 7.6137 9.8187 8.2252 7.0306
6 10.6301 8.7929 7.9902 8.5866 9.0551 8.0204
8 7.7278 10.4637 8.0124 8.8985 6.6688 7.3138
10 ,7.4968 7.7815 6.4283 8.3914 7.7157 6.1180
Analysis of Variance
SS DF MS F
Weeks 14 3 5 1.310
Groups 19 5 4 1.072
Groups
X
Weeks 30 15 2 0.557
Within
Cell 86 24 3.6
Simple Effect
Week within Groups
Group SS DF MS F
1 12 3 4 1.13
2 17 3 6 1.53
3 3 3 1 0.30
4 2 3 0.79 0.22
5 6 3 2 0.55
6 4 3 1 0.34
Group within Weeks
Weeks SS DF MS F
4 14 5 3 0.79
6 10 5 2 0.52
8 18 5 4 1.00
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Fig- 31— Wet weight of liver tissue.
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TABLE 27
ASH WEIGHT OF HEART TISSUE IN GRAMS
Group Means
Group I 2 3 4 5 6
Treatment CC&4 Ethanol Saline + Zn Ethanol + Zn Saline + Zn
Weeks
4 0.0097 0.0Ü90 0.0104 0.0096 0.0100 0.0096
6 0.0II4 0.0094 0.0095 0.0086 0.0100 0.0105
8 0.0082 0.0087 0.0108 0.0096 0.0105 0.0088
10 0.0086 0.0082 0.0090 0.0071 0.0090 0.0097
Analysis of Variance
SS DF MS F
Weeks II58 3 38624 1.996
Groups I08I 5 21635 1.118
Groups
Weeks 1942 15 12949 0.669
Within
Cell 4643 24 19348
Simple Effect
Week within Groups
Group SS DF MS F
I 1208 3 40270 2.08
2 15350 3 5II666 0.26
3 37962 3 12654 0.65
4 84062 3 28020 1.44
5 22909 3 763645 0.39
6 29012 3 967083 0.49
Group within Weeks
Weeks SS DF MS F
4 21493 5 429875 0.22
6 94485 5 18897 0.97
8 1083 5 21663 I.II
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Fig. 32— Per cent ash weight of heart tissue.
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TABLE 28
ASH WEIGHT OF KIDNEY TISSUE IN GRAMS
Group Means
Group 1 2 3 4 5 6
Treatment CCI, Ethanol Saline CC£^ + Zn Ethanol + Zn Saline + Zi
Weeks
4 0.0255 0.0194 0.0244 0.0229 0.0261 0.0230
6 0.0360 0.0361 0.0358 0.0386 0.0369 0.0339
8 0.0260 0.1D233 0.0227 0.0269 0.0241 0.0228
10 0.0308 0.0221 0.0218 0.0234 0.0244 0.0190
Analysis of Variance
SS DF MS F
Weeks 13.79 3 459.90 47.874*
Groups 151.54 5 3030.90 3.154*
Groups
Weeks 129.20 15 86152.2 0.896
Within
Cell 230.58 24 96075
Simple Effect
Week within Groups
Group SS DF MS F
1 130 3 4357 4.33*
2 332 3 110 11.53*
3 256 3 8560 8.91*
4 321 3 107 11.14*
5 221 3 7387 7.68*
6 246 3 8204 8.53*
Group within Weeks
Weeks SS DF MS F
4 6724.6 5 1334.9 1.39
6 2336.3 5 46727.1 0.48
8 3146.6 5 62933.7 0.65
10 158.7 5 3.30*
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Fig. 33— Per cent ash weight of kidney tissue.
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TABLE 29
ASH WEIGHT OF LIVER TISSUE IN GRAMS
Group Means
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CG£^ + Zn Ethanol + Zn Saline + Zn
Weeks
4 0.1279 0.0995 0.1100 0.1429 0.1268 0.1043
6 0.2568 0.1666 0.1293 0.1354 0.1493 0.1324
8 0.1289 0.1605 0.1138 0.1297 0.0956 0.1042
10 0.0866 0.1116 0.0871 0.1348 0.1125 0.0801
Analysis of Variance
SS DF MS F
Weeks 2.3 3 76 2.940
Groups 1.1 5 23 0.894
Groups
X
Weeks 2.4 15 16 0.628
Within
Cell 6.2 24 26
Simple Effect
Week within Groups
Group SS DF MS F
1 3.3 3 1.01 4.19*
2 69 3 23 0.88
3 18 3 609 0.23
4 176 3 5871 0.02
5 31 3 10 0.39
6 27 3 917 0.35
Group within Weeks
Weeks SS DF MS F
4 28 5 555 0.21
6 2.4 5 47 1.81
8 5.3 5 11 0.41
10 44 5 887 0.34
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Fig, 34— Per cent ash weight of liver tissue.
TABLE 30
ZINC, COPPER AND MANGANESE CONTENT OF TOTAL URINE
VOLUME AT TWO WEEKS OF TREATMENT
Group 1 2 3 4 5 6
Treatment CC&p Ethanol Saline CC24 + Zn Ethanol + Zn Saline + Zn
N 8 8 8 8 8 8
Total Vol­
ume of urine 
in ml 















Output in pg 















Output in yg 
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IRON, MAGNESIUM, SODIUM AND POTASSIUM CONTENT OF TOTAL
URINE VOLUME AT TWO WEEKS OF TREATMENT
Group 1 2 3 4 5 6
Treatment CC&1+ Ethanol Saline CC£i4. + Zn Ethanol + Zn Saline + Zn
N 8 8 8 8 8 8
Total Vol­
ume of urine 
in ml 















Output in pg 
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ZINC, COPPER AND MANGANESE CONTENT OF TOTAL URINE 
VOLUME AT FOUR WEEKS OF TREATMENT
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&4 + Zn Ethanol + Zn Saline + Zn
N 8 8 8 8 8 8
Total Vol­
ume of urine 
in ml 
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IRON, MAGNESIUM, SODIUM AND POTASSIUM CONTENT OF TOTAL
URINE VOLUME AT FOUR WEEKS OF TREATMENT
Group 1 2 3 4 5 6
Treatment CC£p Ethanol Saline CC£(+ + Zn Ethanol + Zn Saline + Zn
N 8 8 8 8 8 8
Total Volume 
of Urine in ml 
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MEAN SERUM CONCENTRATIONS OF Mg, Na AND K IN mEq/1
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline i 
mEq/1
CC&4 + Zn 
Mg
Ethanol + Zn Saline + !
Weeks
6 2.32 2.32 2.33 2.98 3.18 2.62
8 2.41 1.68 2.03 1.91 2.75 2.50




6 130 133 135 141 141 135
8 131 129 135 125 135 131




6 4.15 4.65 4.20 4.75 5.12 6.72
8 4.35 4.95 4.45 3.85 4.35 4.85
10 SNS 11.95 12.50 1.70 16.50 12.50
mg% BUN 
Pooled
Sera 24.9 24.0 26.0 29.0 38.9 27.9
SNS = Sample not sufficient.
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TABLE 35
MEAN SERUM CONCENTRATIONS OF Fe, Cu AND An 
IN yg PER 100 ml
Group 1 2 3 4 5 6
Treatment CC&4 Ethanol Saline CC&y + Zn Ethanol -1t Zn Saline
yg Fe per 100 ml
Weeks
6 295 300 330 240 387 390
8 164 200 365 120 80 340
10 SNS 455 550 340 445 555
yg Cu per 100 ml
Weeks
6 104 136 91 105 138 102
8 80 172 94 83 107 90
10 SNS 136 99 204 129 109
yg Zn per 100 ml
Weeks
6 110 104 113 79 107 94
8 76 84 95 82 89 101
10 86 91 101 116 95 92
SNS = Sample not sufficient.
